All Bibliographies

1. Khalid KH, Yamamoto E, Hamajima N, Kariya T. Rates and Factors Associated With Serious Outcomes of Patient Safety Incidents in Malaysia: An Observational Study. Global J Quality and Safety in Healthcare 5: 31-38, 2022.
2. Thanavanh B, Hackpaserd S, Inthaphatha S, Kariya T, Suzuki Y, Yamamoto E, Hamajima N. Underlying cause of death at medical facilities in Xaiyabouli Province, Lao People's Democratic Republic. Nagoya J Med Sci84(2):448-461, 2022.
3. Tran TP, Nguyen DC, Dang TVQ, Tran TK, Vu MH, Le TH, Saw TN, Cho SM, Kariya T, Yamamoto E, Hamajima N, Saw YM. Development of a Vietnamese version of the Revised Hasegawa's Dementia scale. Nagoya J Med Sci 84(2):402-417, 2022.
4. Batbayar B, Kariya T, Boldoo T, Purevdorj E, Dambaa N, Saw YM, Yamamoto E, Hamajima N. Patient delay and health system delay of patients with newly diagnosed pulmonary tuberculosis in Mongolia, 2016-2017. Nagoya J Med Sci 84(2):339-351, 2022.
5. Moeun S, Bhoomikumar J, Pat P, Kariya T, Suzuki Y, Hamajima N, Sok D, Yamamoto E. Children with neuro-developmental disorders at Center for Child and Adolescent Mental Health in Cambodia. Nagoya J Med Sci 84: 593-606, 2022.
6. Sirait LMF, Hamajima N, Suzuki Y, Wahyuningsih ES, Oktavia D, Widyastuti, Inthaphatha S, Nishino K, Yamamoto E. Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: a cross-sectional study. BMC Cancer 22: 1309, 2022.
7. Nishino K, Nishiko Y, Shibata M, Oda Y, Watanabe E, Niimi K, Yamamoto E, Kajiyama H. Cell surface membrane lysosome-associated membrane glycoprotein 2 promotes cell adhesion via abundant N-glycans in choriocarcinoma. Placenta 117: 109-117, 2022.
8. Yamamoto E, Nishino K, Niimi K, Ino K. Epidemiologic study on gestational trophoblastic diseases in Japan. J Gynecol Oncol 33: e72, 2022.
9. Watanabe E, Yokoi A, Yoshida K, Sugiyama M, Kitagawa M, Nishino K, Yamamoto E, Niimi K, Yamamoto Y, Kajiyama H. Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma. Cancer Med. in press.
10. Sonsupap C, Pokhakul P, Kariya T, Suzuki Y, Hamajima N, Yamamoto E. Characteristics of adverse drug reactions due to nonsteroidal anti-inflammatory drugs: a cross-sectional study. Nagoya J Med Sci. in press.
11. Nishino K, Ikeda Y, Kitami K, Niimi K, Kajiyama H. Laparoscopic pelvic surgery after reconstructive surgery with vertical rectus abdominis muscle flap: A case report. Int J Surg Case Rep. 2022 Jan;90:106706. doi: 10.1016/j.ijscr.2021.106706. Epub 2021 Dec 20
12. Inthaphatha S, Louangpradith V, Phoummalaysith B, Thanavanh B, Kariya T, Yamamoto E, Hamajima N. Reporting system on mortality statistics in Lao People's Democratic Republic. Nagoya J Med Sci. in press.

1. Cho SM, Saw YM, Saw TN, Than TM, Khaing M, Khine AT, Kariya T, Soe PP, Oo S, Hamajima N. Prevalence and risk factors of anxiety and depression among the community-dwelling elderly in Nay Pyi Taw Union Territory, Myanmar. Sci Rep 11: 9763, 2021.
2. Fujii R, Kondo T, Tsukamoto M, Kawai S, Sasakabe T, Naito M, Kubo Y, Okada R, Tamura T, Hishida A, Ueyama J, Hayashi Y, Ohnishi J, Hamajima N, Takeuchi K, Wakai K. Association of self-reported moderate vegetable juice intake withsmall decline in kidney function in a five-year prospective study. Nutrition 84: 111114, 2021.
3. Fujii R, Yamamda H, Munetsuna E, Yamazaki M, Mizuno G, Ando Y, Maeda K, Tsuboi Y, Ohashi K, Ishikawa H, Hagiwara C, Wakai K, Hashimoto S, Hamajima N, Suzuki K. Dietary fish and v-3 polyunsaturated fatty acids are associated with leukocyte ABCA1 DNA methylation levels. Nutrition 81: 110951, 2021.
4. Fujii R, Yamada H, Tsuboi Y, Ando Y, Munetsuna E, Yamazaki M, Ohashi K, Ishikawa H, Ishihara Y, Hashimoto S, Hamajima N, Suzuki K. Association between circulating microRNAs and changes in kidney function: A five-year prospective study among Japanese adults without CKD. Clin Chim Acta 521: 97-103, 2021.
5. Keng ZY, Saw YM, Thung SC, Chong WW, Albert A, Kariya T, Yamamoto E, Hamajima N. Rate of achievement of therapeutic outcomes and factors associated with control of non-communicable diseases in rural east Malaysia: implications for policy and practice. Sci Rep 11: 3812, 2021.
6. Leak P, Yamamoto E, Noy P, Keo D, Krang S, Kariya T, Saw YM, Siek M, Hamajima N. Factors associated with neonatal mortality in a tertiary hospital in Phnom Penh, Cambodia. Nagoya J Med Sci 83: 113-124, 2021.
7. Nakamura K, Niimi K, Yamamoto E, Ikeda Y, Nishino K, Suzuki S, Kajiyama H, Kikkawa F. Core 2 B1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity. Biochem Biophys Rep 26: 100951, 2021.
8. Nakashima T, Katayama N, Saji N, Teranishi M, Yoshida T, Suzuki H, Sone M, Hamajima N. Dietary habits and medical examination findings in Japanese adults middle-aged or older who live alone. Nutrition. 89: 111268, 2021.
9. Nguyen TTN, Kotani T, Imai K, Ushida T, Moriyama Y, Kobayashi T, Niimi K, Sumigama S, Yamamoto E, Vo VD, Le MT, Le LH, Nguyen DN, Nguyen VQH, Truong QV, Cao NT, Kikkawa F. Assessment of myocardial performance index in late-onset fetal growth restriction. Nagoya J Med.Sci 83: 259-268, 2021.
10. Niimi K, Yamamoto E, Morita S, Morikawa M, Hattori H, Hatakeyama M, Morita M, Nishino K, Oda Y, Watanabe E, Yamamoto T, Kajiyama H, Kikkawa F. Next generation genome sequencing of a matched normal tumor pair from a patient with intractable gestational choriocarcinoma: A case report. Mol Clin Concol 15: 143, 2021.
11. Nishino K, Yamamoto E, Ikeda Y, Niimi K, Yamamoto T, Kaijiyama H. A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review. J Ovarian Res 14: 56, 2021.
12. Nishino K, Yamamoto E, Oda Y, Watanabe E, Niimi K, Yamamoto T, Kajiyama H. Short tandem repeat analysis to identify the causative pregnancy of high-risk gestational trophoblastic neoplasia: Molar versus nonmolar pregnancy and its relation to the outcome. Placenta 112: 28-35, 2021.
13. Nishino K, Yamamoto E, Oda Y, Watanabe E, Niimi K, Yamamoto T, Kajiyama H. Short tandem repeat analysis to identify the causative pregnancy of high-risk gestational trophoblastic neoplasia: Molar versus nonmolar pregnancy and its relation to the outcome. Placenta 112: 28-35, 2021.
14. Senavong P, Yamamoto E, Keomoungkhoune P, Pratith N, Somoulay V, Kariya T, Saw YM, Pongvongsa T, Hamamjima N. Factors associated with severe dengue in Savannakhet Province, Lao People's Demoratic Republic. Nagoya J Med Sci, (4):749-763, 2021.
15. Sunagawa Y, Yamada S, Sonohara F, Kurimoto K, Tanaka N, Suzuki Y, Inokawa Y, Takami H, Hayashi M, Kanda M, Tanaka C, Nakayama G, Koike M, Kodera Y. Genome wide identifcation and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue. Sci Rep 11: 6016, 2021.
16. Suzuki K, Yamada H, Fujii R, Munetsuna E, Ando Y, Ohashi K, Ishikawa H, Yamazaki M, Maeda K, Hashimoto S, Hamajima N. Association between circulating vascular-related microRNAs and an increase in blood pressure: a 5-year longitudinal population-based study. J Hypertens 39: 84-89, 2021.
17. Than MW, Zaw NT, MinnK, Saw YM, Kiriya J, Jimba M, Win HH, Shibanuma A. Assessing depressive symptoms among people living with HIV in Yangon city, Myanmar: Does being a member of self-help group matter? PLoS One. 16: e0248807, 2021.
18. Tsuboi Y, Yamada H, Munetsuna E, Fujii R, Yamazaki M, Ando Y, Mizuno G, Ishikawa H, Ohashi K, Hashimoto S, Hamajima N, Suzuki K. Global DNA hypermethylation in peripheral blood mononuclear cells and cardiovascular disease risk: a population-based propensity score-matched cohort study. J Epidemiol Commun Health. J Epidemiol Comm Health: jech-2020-215382, 2021.
19. Yamamoto E, Kanal K, Soeung SC, Fujita N, Krang S, Long-Hay P, Nishino K, Niimi K, Hamamjima N. The current situation of health services for hydatidiform mole in Cambodia. J Obstet Gynaecol Res. 47(10):3652-3660, 2021.
20. Yamazaki M, Yamada H, Munetsuna E, Maeda K, Ando Y, Mizuno G, Fujii R, Tsuboi Y, Ohashi K, Ishikawa H, Hashimoto S, Hamajima N, Suzuki K. DNA methylation level of the gene encoding thioredoxin-interacting protein in peripheral blood cells is associated with metabolic syndrome in the Japanese general population. Endocr J 21-0339, 2021.
21. Inthaphatha S, Louangpradith V, Xiong LI, Xiong V, Ly L, Xaitengcha V, Phengsavanh A, Hamajima N, Yamamoto E. Menstrual health and factors asociated with school absence among secondary school girls in Luang Prabang Province, Lao People's Democratic Republic: A cross- sectional study. PLoS One16(12):e0261268, 2021.

1. Cho SM, Saw YM, Latt NN, Saw TN, Htet H, Khaing M, Than TM, Win EM, Aung ZZ, Kairya T, Yamamoto E, Hamajima N. Cross-sectional study on tobacco advertising, promotion and sponsorship (TAPS) and violations of tobacco sale regulations in Myanmar: do these factors affect current tobacco use among Myanmar high school students? BMJ Open 10: e031933, 2020.
2. Choda N, Wakai K, Naito M, Imaeda N, Goto C, Maruyama K, Kadomatsu Y, Tsukamoto M, Sasakabe T, Kudo Y, Okada R, Kawai S, Tamura T, Hishida A, Takeuchi K, Mori A, Hamajima N. Associations between diet and mental health using the 12-item General Health Questionnaire: cross-sectional and prospective analyses from the Japan Multi-Institutional Collaborative Cohort Study. Nutr J 19: 2, 2020.
3. Fujii R, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Ando Y, Maeda K, Tsuboi Y, Ohashi K, Ishikawa H, Hagiwara C, Wakai K, Hashimoto S, Hamajima N, Suzuki K. Dietary fish and ω-3 polyunsaturated fatty acids are associated with leukocyte ABCA1 DNA methylation levels. Nutrition 81: 110951, 2020.
4. Houattongkham S, Yamamoto E, Sithivong N, Inthaphatha S, Kariya T, Saw YM, Vongduangchanh A, Keosavanh O, Hamajima N. Etiologic agents of acute diarrhea in sentinel surveillance sites in Vientiane Capital, Lao People's Democratic Republic, 2012-2015. Eur J Clin Microbiol Infect Dis 39(6): 1115-1122, 2020.
5. Htet H, Saw YM, Saw TN, Htun NMM, Lay MonK, Cho SM, Thike T, Khine AT, Kariya T, Yamamoto E, Hamajima N. Prevalence of alcohol consumption and its risk factors among university students: A cross-sectional study across six universities in Myanmar. PLoS One 15(2); e0229329, 2020.
6. Inthaphatha S, Yamamoto E, Louangpradith V, Takahashi Y, Phengsavanh A, Kariya T, Saw YM, Hamajima N. Factors associated with postpartum depression among women in Vientiane Capital, Lao People's Democratic Republic: A cross-sectional study. PLoS One 15(12):e0243463, 2020.
7. Khaing M, Saw YM, Than TM, Mon AM, Cho SM, Saw TN, Kariya T, Yamamoto E, Hamajima N. Geographic distribution and utilization of CT and MRI services at public hospitals in Myanmar. BMC Health Serv Res 20: 742, 2020.
8. Khine AT, Saw YM, Htut ZY, Khaing CT, Soe HZ, Win KK, Thike TZ, Htet H, Saw TN, Cho SM, Kariya T, Yamamoto E, Hamajima N. Assessing risk factors and impact of cyberbullying victimization among university students in Myanmar: A cross-sectional study. PLoS One 15(1): e0227051, 2020.
9. Louangpradith V, Phoummalaysith B, Kariya T, Saw YM, Yamamoto E, Hamajima N. Disease frequency among inpatients at a tertiary general hospital in Lao PDR. Nagoya J Med Sci 82. 113-121, 2020.
10. Louangpradith V, Yamamoto E, Inthaphatha S, Phoummalaysith B, Kariya T, Saw YM, Hamajima N. Trends and risk factors for infant mortality in the Lao People's Democratic Republic. Sci Rep 10: 21723, 2020.
11. Maeda K, Yamada H, Munetsuna E, Fujii R, Yamazaki M, Ando Y, Mizuno G, Ishikawa H, Ohashi K Tsuboi Y, Hashimoto S, Hamajima N, Suzuki K. Association of smoking habits with TXNIP DNA methylation levels in leukocytes among general Japanese population. PLoS One 15: e0235486, 2020.
12. Matsunaga T, Naito M, Yin G, Hishida A, Okada R, Kawai S, Sasakabe T, Kadomatsu Y, Tsukamoto M, Kubo Y, Tamura T, Takeuchi K, Mori A, Hamajima N, Wakai K. Associations between peroxisome proliferator-activated receptor γ (PPAR-γ) polymorphisms and serum lipis: two cross-sectional studies of community-dwelling adults. Gene 762: 145019, 2020.
13. Noe MTN, Saw YM, Saw TN, Kyaw YP, Zin PE, Kariya T, Yamamoto E, Win HH, Wann T, Hamajima N. Assessment of nutritional status and risk factors for malnutrition among the elderly in Loikaw, Myanmar. Nutrition 79-80: 110933, 2020.
14. Sato S, Yamamoto E, Niimi K, Ino K, Nishino K, Suzuki S, Kotani T, Kajiyama H, Kikkawa F. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia. Int J Clin Oncol. 25(1):203-209, 2020.
15. Saw YM, Than TM, Khaing M, Soe PP, Oo S, Cho SM, Win EM, Saw TN, Fuchita E, Kariya T, Iriyama S, Hamajima N. Cognitive impairment and its risk factors among Myanmar elderly using the Revised Hasegawa's Dementia Scale: A cross-sectional study in Nay Pyi Taw, Myanmar. PLoS One 15: e0236656, 2020.
16. Sereenen E, Saw YM, Erkhembayar R, Volodya B, Otgonbayar D, O Orsoo, Kariya T, Ochir C, Yamamoto E, Hamajima N. Estimation of the unvaccinated among those aged less than 25 years according to aimag and its association with incidence of measles outbreak 2015-2016 in Mongolia. Nagoya J Med Sci 82: 437-447, 2020.
17. Sudo M, Hashimoto K, Yoshinaga M, Azimi MD, Fayaz SH, Hamajima N, Kondo-Ida L, Yanagisawa K, Kato M. Lithium promotes malignant transformation of nontumorigenic cells in vitro. Sci Total Environ 744: 140830, 2020
18. Taazan B, Yamamoto E, Baatar B, Amgalanbaatar A, Kariya T, Saw YM, Hamajima N. Estimating cost of hospitalization for childbirth at a tertiary hospital in Mongolia. Nagoya J Med Sci 82: 47-57, 2020.
19. Tam LM, Kotani T, Linh TM, Thu PTM, Khanh TV, Anh NTK, Nguyen NTT, Moriyama Y, Yamamoto E, Huy NVQ, Vinh TQ, Thanh CN, Kikkawa F. Outcome of cesarean scar pregnancy treated with local methotrexate injection. Nagoya J Med Sci. 82(1):15-23, 2020.
20. Thike TZ, Saw YM, Lin H, Chit K, Tun AB, Htet H, Cho SM, Khine AT, Saw TN, Kraiya T, Yamamoto E, Hamajima N. Association between body mass index and ready-to-eat food consumption among sedentary staff in Nay Pyi Taw union territory, Myanmar. BMC Public Health 20: 206, 2020.
21. Wasiq AN, Saw YM, Jawid S, Kariya T, Yamamoto E, Hamajima N. Determinants of diarrhea in children under the age of five in Afghanistan: A secondary analysis of the Afghanistan Demographic and Health Survey 2015. Nagooya J Med Sci 82: 545-556, 2020.
22. Xu H, Hashimoto K, Maeda M, Azimi MH, Fayaz SH, Chen W, Hamajima N, Kato M. High levels of boron promote anchorage-independent growth of nontumorigenic cells. Environ Pollut 266: 115094, 2020.
23. Yamamoto E, Nishino K, Niimi K, Watanabe E, Oda Y, Ino K, Kikkawa F. Evaluation of a routine second curettage for hydatidiform mole: a cohort study. Int J Clin Oncol. 25: 1178-1186, 2020.
24. Yamamoto E, Trinh TD, Sekiya Y, Tamakoshi K, Nguyen XP, Nishino K, Niimi K, Kotani T, Kajiyama H, Shibata K, Le QT, Kikkawa F. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study. Nagoya J Med Sci. 82: 183-191, 2020.
25. Zin PE, Saw YM, Saw TN, Cho SM, Hlaing SS, Noe MTN, Kariya T, Yamamoto E, Lwin KT, Win HH, Hamajima N. Assessment of quality of life among elderly in urban and peri-urban areas, Yangon Region, Myanmar. PLoS One 15(10):e0241211, 2020.

1. Alam Z, Higuchi M, Sarker MAB, Hamajima N. Mass media exposure and childhood diarrhea: A secondary analysis of the 2011 Bangladesh Demographic and Health Survey. Nagoya J Med Sci 81: 31-40, 2019.
2. Ando Y, Yamazaki M, Yamada H, Munetsuna E, Fujii R, Mizuno G, Ichino N, Osakabe K, Sugimoto K, Ishikawa H, Ohashi K, Teradaira R, Ohta Y, Hamajima N, Hashimoto S, Suzuki K. Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population. Sci Rep 9: 18856, 2019.
3. Aung ZZ, Saw YM, Saw TN, Oo N, Aye HNN, Aung S, Oo HN, Cho SM, Khaing M, Kariya T, Yamamoto E, Hamajima N. Survival rate and mortality risk factors among TB-HIV co-infected patients at a HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study. Int J Infect Dis 80: 10-15, 2019.
4. Azimi MW, Yamamoto E, Saw YM, Kariya T, Arab AS, Sadaat SI, Farzad F, Hamajima N. Factors associated with antenatal care visits in Afghanistan: secondary analysis of Afghanistan Demographic and Health Survey 2015. Nagoya J Med Sci 81: 121-131, 2019.
5. Fujii R, Hishida A, Suzuki K, Hamajima N, Wakai K, Kondo T. Cluster of differentiation 36 gene polymorphism (rs1761667) is associated with dietary MUFA intake and hypertension in a Japanese population. Br J Nutr 121:1215-1222, 2019.
6. Fujii R, Ueyama J, Kanno T, Suzuki K, Hamajima N, Wakai K, Hasegawa Y, Kondo T. Human serum albumin redox state is associated with decreased renal function in a community-dwelling population. Am J Physiol Renal Physiol 316: F214-F218, 2019.
7. Fujii R, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Ando Y, Hagiwara C, Maeda K, Hashimoto S, Hamajima N, Suzuki K. Dietary vegetable intake is inversely associated with ATP-binding cassette protein A1 (ABCA1) DNA methylation levels among Japanese women. Nutrition 65: 1-5, 2019.
8. Htin Aung Myint MN, Yamamoto E, Ko MN, Khaing M, Reyer JA, Hamajima N. Knowledge, attitude, and usage pattern of tobacco among high school students in Nay Pyi Taw, Myanmar. Nagoya J Med Sci 81: 65-79, 2019.
9. Iriyama T, Wang G, Yoshikawa M, Mimura N, Matsui H, Sayama S, Kumasawa K, Nagamatsu T, Koga K, Kotani T, Niimi K, Yamamoto E, Kellems RE, Xia Y, Osuga Y, Fujii T. Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia. Sci Rep 9:10107, 2019.
10. Jigjidsuren A, Byambaa T, Altangerel E, Batbaatar S, Saw YM, Kariya T, Yamamoto E, Hamajima N. Free and Universal Access to Primary Healthcare in Mongolia: The Service Availability and Readiness Assessment. BMC Health Serv Res 19: 129, 2019.
11. Kaur J, Hamajima N, Yamamoto E, Saw YM, Kariya T, Soon GC, Amin A, Halim AN, Aziz FA, Sharon SH. Patient satisfaction on the utilization of traditional and complementary medicine services at public hospital in Malaysia. Complement Ther Med 42: 422-428, 2019.
12. Keohavong B, Vonglokham M, Phoummalaysith B, Louangpradith V, Inthaphatha S, Kariya T, Saw YM, Yamamoto E, Hamajima N. Antibiotic prescription for under-fives with common cold or upper respiratory tract infection in Savannakhet Province, Lao PDR. Trop Med Health 47: 16, 2019.
13. Kadomatsu Y, Tsukamoto M, Sasakabe T, Kawai S, Naito M, Kubo Y, Okada R, Tamura T, Hishida A, Mori A, Hamajima N, Yokoi K, Wakai K. A risk score predicting new incidence of hypertension in Japan. J Hum Hypertension 33: 748-755, 2019.
14. Kajiyama H, Suzuki S, Utsumi F, Yoshikawa N, Nishino K, Ikeda Y, Niimi K, Yamamoto E, Kawai M, Shibata K, Nagasaka T, Kikkawa F. Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma. Int J Clin Oncol 24:950-956, 2019.
15. Kounnavong S, Ratsavong K, Soundavong K, Xayavong S, Kariya T, Saw YM, Yamamoto E, Horibe K, Toba K, Hamajima N. Cognitive function measured with the Revised Hasegawa's Dementia Scale among elderly individuals in Lao PDR. Nagoya J Med Sci 81: 281-290, 2019.
16. Long-Hay P, Yamamoto E, Bun S, Savuth T, Buntha S, Sokdaro S, Kariya T, Saw YM, Sengdoeurn Y, Hamajima N. Outbreak detection of influenza-like illness in Prey Veng Province, Cambodia: A community-based surveillance. Nagoya J Med Sci 81: 269-280, 2019
17. Mizuno M, Miki R, Moriyama Y, Ushida T, Imai K, Niimi K, Nakano T, Tsuda H, Sumigama S, Yamamoto E, Senga T, Iwase A, Kikkawa F, Kotani T. The role of E2F8 in the human placenta. Mol Med Rep 19:293-301, 2019.
18. Narin P, Yamamoto E, Saw YM, Net N, Inthaphatha S, Kariya T, Hamajima N. Factors associated with HIV testing among the general male population in Cambodia: A secondary data analysis of the Demographic Health Survey in 2005, 2010 and 2014. PLoS One 14: e0219820, 2019.
19. Oo N, Saw YM, Aye HNN, Aung ZZ, Kyaw HN, Tun AM, Kariya T, Yamamoto E, Hamajima N. Consumption of foods containing prohibited artificial colors among middle-school children in Nay Pyi Taw Union Territory, Myanmar. BMC Public Health 19: 344, 2019.
20. Orsoo O, Saw YM, Sereenen E, Yadamsuren B, Byambaa A, Kariya T, Yamamoto E, Hamajima N. Epidemiological characteristics and trends of a nationwide measles outbreak in Mongolia, 2015–2016. BMC Public Health 19: 201, 2019.
21. Saw YM, Than TM, Thaung Y, Aung S, Wen-Shuan Shiao L, Win EM, Khaing M, Tun NA, Iriyama S, Win HH, Sakisaka K, Jimba M, Hamajima N, Saw TN. Myanmar's human resources for health: current situation and its challenges. Heliyon 5: e01390, 2019.
22. Win EM, Saw YM, Oo KL, Than TM, Cho SM, Kariya T, Yamamoto E, Hamajima N. Healthcare waste management at primary health centres in Mon State, Myanmar: the comparisons between hospital and non-hospital type primary health centres. Nagoya J Med Sci 81: 81-91, 2019.
23. Yrysov K, Tursunov D, Reyer JA, Yamamoto E, Yrysova M, Hamajima N. Multiple ruptured cerebral aneurysms at the National Hospital of the Kyrgyz Republic between 2008 and 2014: A departmental summary. Nagoya J Med Sci 81: 511-518, 2019.
24. Shigemoto E, Mizuno M, Suzuki Y, Kobayashi K, Sakata F, Kariya T, Katsuno T, Maruyama S, Ito Y. Increase of Eosinophil in Dialysate During Induction of Peritoneal Dialysis. Perit Dial Int 39(1):90-92, 2019.

1. Aye HNN, Saw YM, Thar AMC, Oo N, Aung ZZ, Tin H, Kariya T, Yamamoto E, Hamajima N. Accessing the operational costs of routine immunization activities at sub-centers level in Myanmar: what matters to increase a national immunization coverage? Vaccine 36: 7542-7548, 2018.
2. Fujii R, Hishida A, Wu MC, Kondo T, Hattori Y, Naito M, Endoh K, Nakatochi M, Hamajima N, Kubo M, Kuriki K, Wakai K. Genome-wide association study for pollinosis identified two novel loci in interleukin (IL)-1B in a Japanese population. Nagoya J Med Sci 80: 109-120, 2018.
3. Fujii R, Ueyama J, Aoi A, Ichino N, Osakabe K, Sugimoto K, Suzuki K, Hamajima N, Wakai K, Kondo T. Oxidized human serum albumin as a possible correlation factor for atherosclerosis in a rural Japanese population: The results of the Yakumo Study. Envrion Health Prev Med 23: 1, 2018.
4. Kariya T, Nishimura H, Mizuno M, Suzuki Y, Matsukawa Y, Sakata F, Maruyama S, Takei Y, Ito Y. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis. Am J Physiol Renal Physiol 314(2): F167-F180, 2018.
5. Moroi H, Kotani T, Miki R, Tsuda H, Mizuno M, Ito Y, Ushida T, Imai K, Nakano T, Li H, Sumigama S, Yamamoto E, Iwase A, Kikkawa F. The expression of Toll-like receptor 5 in preterm histologic chorioamnionitis. J Clin Biochem Nutr 62(1): 63-67, 2018.
6. Munetsuna E, Yamada H, Ando Y, Yamazaki M, Tsuboi Y, Kondo M, Mizuno G, Ishikawa H, Sugimoto K, Osakabe K, Ichino N, OhashiK, Hamajima N, Suzuki K. Association of subcuta neous and visceral fat with circulating microRNAs in a middle-aged Japan ese population. Ann Clin Biochem 55: 437-445, 2018.
7. Nakamura K, Kajiyama H, Utsumi F, Suzuki S, Niimi K, Sekiya R, Sakata J, Yamamoto E, Shibata K, Kikkawa F. Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas. Mol Clin Oncol 8(3): 499-503, 2018.
8. Nishino K, Koda S, Kataoka N, Takamatsu S, Nakano M, Ikeda S, Kamamatsu Y, Morishita K, Moriwaki K, Eguchi H, Yamamoto E, Kikkawa F, Tomita Y, Kamada Y, Miyoshi E. Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation. Oncotarget 9(16): 12732-12744, 2018.
9. Noe MTN, Saw YM, Soe PP, Khaing M, Saw TN, Hamajima N, Win HH. Barriers between mothers and their adolescent daughters with regards to sexual and reproductive health communication in Taunggyi Township, Myanmar: What factors play important roles?. PLoS One 13: e208849, 2018.
10. Nyi Latt N, Saw YM, Myat Cho S, Kariya T, Yamamoto E, Hamajima N. Tobacco Control Law awareness, enforcement, and compliance among high school students in Myanmar. Nagoya J Med Sci 80: 379-389, 2018.
11. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Trace proteinuria by dipstick screening is associated with metabolic syndrome, hypertension, and diabetes. Clin Exp Nephrol 22: 1387-1394, 2018.
12. Phoummalaysith B, Yamamoto E, Xeuatvongsa A, Louangpradith V, Keohavong B, Saw YM, Hamajima N. Factors associated with routine immunization coverage of children under one year old in Lao People's Democratic Republic. Vaccine 36: 2666-2672, 2018.
13. Rasekh B, Saw YM, Azimi S, Kariya T, Yamamoto E, Hamajima N. Associations of treatment completion against drug addiction with motivational interviewing and related factors in Afghanistan. Nagoya J Med Sci 80: 329-340, 2018.
14. Sasakabe T, Wakai K, Kawai S, Hishida A, Naito M, Suzuki S, Nindita Y, Arisawa K, Kita Y, Hara M, Kuriyama N, Hirata A, Mikami H, Oze I, Kubo M, Tanaka H, Hamajima N, for the J-MICC Study Group. Modification of the association of alcohol intake with serum low-density lipoprotein cholesterol and triglycerides by ALDH2 and ADH1B polymorphisms in Japanese men. J Epidemiol 28: 185-193, 2018.
15. Saw TN, Yasuoka J, Saw YM, Than TM, Win EM, Aung ZZ, Cho SM, Shibanuma A, Poudel KC, Win HH, Iriyama S, Jimba M. Factors associated with concurrent sexual partnerships among men who have sex with men in Yangon, Myanmar. Nagoya J Med Sci 80: 505-518, 2018.
16. Saw YM, Saw TN, Chan N, Cho SM, Jimba M. Gender-specific differences in high-risk sexual behaviors among methamphetamine users in Myanmar-China border city, Muse, Myanmar: who is at risk? BMC Public Health 18:209, 2018.
17. Saw YM, Than TM, Win EM, Cho SM, Khaing M, Latt NN, Aung ZZ, Oo N, Aye HNN, Kariya T, Yamamoto E, Hamajima N. Myanmar language version of the Revised Hasegawa's Dementia Scale. Nagoya J Med Sci 80: 435-450, 2018.
18. Seiki T, Naito M, Hishida A, Takagi S, Matsunaga T, Sasakabe T, Hattori Y, Kawai S, Okada R, Yin G, Hamajima N, Wakai K. Association of genetic polymorphisms with erythorocyte traits: Verification of SNPs reorted in a previous GWAS in a Japanese population. Gene 642: 172-177, 2018.
19. Sor S, Higuchi M, Sarker MAB, Hamajima N. Knowledge of rabies and dog-related behaviors among people in Siem Reap Province, Cambodia. Trop Med Health 46: 20, 2018.
20. Thi Thao Nguyen S, Yamamoto E, Thi Ngoc Nguyen M, Bao Le H, Kariya T, Saw YM, Duc Nguyen C, Hamajima N. Waiting time in the outpatients clinic at a national hospital in Vietnam. Nagoya J Med Sci 80: 227-239, 2018.
21. Tien Dat T, Kotani T, Yamamoto E, Shibata K, Moriyama Y, Tsuda H, Yamashita M, Kajiyama H, Duc Thien Minh D, Quang Thanh L, Kikkawa F. Dengue fever during pregnancy. Nagoya J Med Sci 80: 241-247, 2018.
22. Tsuboi Y, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Murase Y, Ohashi K, IshikawaK, Kondo M, Inoue T, Hashimoto N, Hamajima N, Suzuki K. Relationship between long interspersed nuclear element-1 DNA methylation in leukocytes and dyslipidemia in the Japanese general population. J Atheroscler Thrombo 25: 1231-1239, 2018.
23. Tursunov D, Yoshida Y, Yrysov K, Sabirov D, Alimova K, Yamamoto E, Reyer JA, Hamajima N. Estimated costs for treatment and prophylaxis of newborn vitamin K deficiency bleeding in Tashkent, Uzbekistan. Nagoya J Med Sci 80: 11-20, 2018.

1. Chankham T, Yamamoto E, Reyer JA, Arafat R, Khonemany I, Panome S, Hongkham D, Bounfeng P, Anonh X, Hamajima N. Knowledge of free delivery policy among women who delivered at health facilities in Oudomxay Province, Lao PDR. Nagoya J Med Sci 79: 135-145, 2017.
2. Farzad F, Reyer JA, Yamamoto E, Hamajima N. Socio-economic and demographic determinants of full immunization among children of 12-23 months in Afghanistan. Nagoya J Med Sci 79: 179-188, 2017.
3. Hatta T, Kato K, Hotta C, Higashikawa M, Iwahara A, Hatta T, Hatta J, Fujiwara K, Nagahara N, Ito E, Hamajima N. Visual search load effects on age-related cognitive decline: evidence from Yakumo Longidudinal Study. Am J Psychol 130: 73-82, 2017.
4. Inthanomchanh V, Reyer JA, Blessmen J, Pharasisombath K, Yamamoto E, Hamajima N. Assessment of knowledge about snakebite management amongst healthcare providers in the provincial and two district hospitals in Savannakhet Province, Lao PDR. Nagoya J Med Sci 79: 299-311, 2017.
5. Islam MJ, Rahman M, Broidy L, Haque SE, Saw YM, Duc NH, Haque MN, Rahman MM, Islam MR, Mostofa MG. Assessing the link between witnessing inter-parental violence and the perpetration of intimate partner violence in Bangladesh. BMC Public Health 17: 183, 2017.
6. Kounnavong S, Soundavong K, Xayavong S, Vongpraserth N, Bounsavath P, Houatthongkham S, Phoummalaysith B, Saw YM, Yamamoto E, Toba K, Hamajima N. Lao language version of the Revised Hasegawa’s Dementia Scale. Nagoya J Med Sci 79: 241-249, 2017.
7. Niimi K, Yamamoto E, Nishino K, Fujiwara S, Ino K, Kikkawa F, Spontaneous regression of gestational trophoblastic neoplasia. Spontaneous regression of gestational trophoblastic neoplasia. Gynecol Oncol Rep 21: 98-100, 2017.
8. Nishino K, Yamamoto E, Niimi K, Sekiya Y, Yamashita Y, Kikkawa F. N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma. Oncol Rep 38: 440-448, 2017.
9. Okada R, Naito M, Hattori Y, Seiki T, Wakai K, Nanri H, Watanabe M, Suzuki S, Kairupan TS, Takashima N, Mikami H, Ohnaka K, Watanabe Y, Kamano SK, Kubo M, Hamajima N, Tanaka H; The Japan Multi-institutional Collaborative Cohort Study Group. Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer. Gastric Cancer 20: 246-253, 2017.
10. Phoummalaysith B, Louangpradith V, Manivon T, Keohavong B, Yamamoto E, Hamajima N. Underlying cause of death recorded during 2013 to 2015 at a tertiary general hospital in Vientiane Capital, Lao PDR. Nagoya J Med Sci 79: 199-209, 2017.
11. Rahman M, Islam MJ, Haque SE, Saw YM, Haque MN, Duc NH, Al-Sobaihi S, Saw TN, Mostofa MG, Islam MR. Association between high-risk fertility behaviours and the likelihood of chronic undernutrition and anaemia among married Bangladeshi women of reproductive age. Public Health Nutr 20: 305-314, 2017.
12. Sakata J, Utsumi F, Suzuki S, Niimi K, Yamamoto E, Shibata K, Senga T, Kikkawa F, Kajiyama H. Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.Oncotarget 8(59):99482-99494, 2017.
13. Saw YM, Saw TN, Yasuoka J, Chan N, Kham NPE, Khine W, Cho SM, Jimba M. Gender difference in early initiation of methamphetamine use among current methamphetamine users in Muse, Northern Shan State, Myanmar. Harm Reduct J 14:21, 2017.
14. Sekiya Y, Yamamoto E, Niimi K, Nishino K, Nakamura K, Kotani T, Kajiyama H, Shibata K, Kikkawa F. c-Rel Promotes Invasion of Choriocarcinoma Cells via PI3K/AKT Signaling. Oncology 92: 299-310, 2017.
15. Takagi S, Naito M, Kawai S, Okada R, Nagata C, Hosono S, Nishida Y, Takashima N, Suzuki S, Shimoshikiryo I, Mikami H, Uemura H, Kuriyama N, Ohnaka K, Kubo M, Hamajima N, Tanaka H, Wakai K. Macronutrient intakes and serum estrogen, and interaction with polymorphisms in CYP19A1 and HSD17B1 genes: A cross-sectional study in postmenopausal Japanese women. Br J Nutr 118: 463-472, 2017.
16. Than TM, Saw YM, Khaing M, Win EM, Cho SM, Kariya T, Yamamoto E, Hamajima N. Unit cost of healthcare services at 200-bed public hospitals in Myanmar: what plays an important role of hospital budgeting? BMC Health Serv Res 17: 669, 2017.
17. Yamamoto E, Niimi K, Kiyono T, Yamamoto T, Nishino K, Nakamura K, Kotani T, Kajiyama H, Shibata K, Kikkawa F. Establishment and characterization of cell lines derived from complete hydatidiform mole. Int J Mol Med 40: 614-622, 2017.
18. Hamajima N, Sugimoto T, Hasebe R, Cho SM, Saw YM, Khaing M, Kariya T, Yamamoto E. Medical facility statistics in Japan. Nagoya J Med Sci 79: 515-525, 2017.

1. Asaduzzaman M, Higuchi M, Sarkar MAB, Hamajima N. Awareness and knowledge of HIV/AIDS among married women in rural Bangladesh and exposure to media: a secondary data analysis of the 2011 Bangladesh Demographic and Health Survey. Nagoya J Med Sci 78: 109-118, 2016.
2. Frozanfar MK, Yoshida Y, Yamamoto E, Reyer JA, Dalil S, Rahimzad AD, Hamajima N. Acute malnutrition among under-five children in Faryab, Afghanistan: prevalence and causes. Nagoya J Med Sci 78: 41-53, 2016.
3. Hattori Y, Naito M, Sato M, Takagi S, Matsunaga T, Seiki T, Sasakabe T, Suma S, Kawai S, Okada R, Hishida A, Hamajima N, Wakai K. Metallothionein 2A gene A-5G as a risk factor for chronic kidney disease and diabetes: Cross-sectional and cohort study. Toxicol Sci 152: 181-193, 2016.
4. Higashibata T, Wakai K, Naito M, Morita E, Hishida A, Hamajima N, Hara M, Suzuki S, Hosono S, Takashima N, Ohnaka K, Takada A, Mikani H, Watanabe Y, Uemura H, Kubo M,Tanaka H. Effects of self-reported calorie restriction on correlations between SIRT1 polymophisms and body mass index and long-term weight change. Gene 594: 16-22, 2016.
5. Higashibata T, Wakai K, Okada R, Nakagawa H, Hamajima N. Associations of smoking status with other lifestyle behaviours are modified by sex and occupational category among urban civil servants in Japan. Environ Health Prev Med 21: 539-546, 2016.
6. Htun NMM, Reyer JA, Yamamoto E, Yoshida Y, Hamajima N. Trends in attrition among medical teaching staff at universities in Myanmar 2009-2013. Nagoya J Med Sci 78: 27-40, 2016.
7. Hung NV, Thu TA, Yagi T, Hamajima N, Anh NQ. Surgical site infection prevention: what are the gaps in Vietnamese hospitals? Can J Infect Cont 31: 18-23, 2016.
8. Kikuchi K, Okawa S, Zamawe CO, Shibanuma A, Nanishi K, Iwamoto A, Saw YM, Jimba M. Effectiveness of Continuum of Care-Linking Pre-Pregnancy Care and Pregnancy Careto Improve Neonatal and Perinatal Mortality: A Systematic Review and Meta-Analysis. PLoS One 11: e0164965, 2016.
9. Kamei H, Masuda S, Ishigami M, Nakamura T, Fujimoto Y, Takada Y, Hamajima N. Association of interleulin4 gene polymorphisms of recipients and donors with acute rejection following living donor liver transplantation. Clin Res Hepatol Gastroenterol 40: 179-185, 2016.
10. Kamei H, Nakamura T, Nagai S, Ishigami M, Hamajima N. Possible association between the methylenetetrahydrofolate reductase gene C677T polymorphism and preexisting portal vein thrombosis in liver transplant recipients. Exp Clin Transplant 14: 313-316, 2016.
11. Kamei H, Onishi Y, Nakamura T, Ishigami M, Hamajima N. Role of cytokine gene polymorphisms. Hepatol Intin acute and chronic kidney disease following liver transplantation. Hepatol Int 10: 665-672, 2016.
12. Kan M, Yamamoto E, Niimi K, Tamakoshi K, Sekiya Y, Nishino K, Ino K, Kikkawa F. Gestational trophoblastic neoplasia and pregnancy outcome after routine second curettage for hydatidiform mole: A retrospective observational study. J Reprod Med 61: 373-379, 2016.
13. Kato M, Azimi MD, Fayaz SH, Shah MD, Hoque MD, Hamajima N, Ohnuma S, Ohtsuka T, Maeda M, Yoshinaga M. Uraniumin in well drinking water of Kabul, Afghanistan and its effective, low-cost depuration using Mg-Ge based hydrotalcite-like compounds. Chemospher 165: 27-32, 2016.
14. Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Chiba T, Takahashi A, Nakamura T, Nakashima H, Takada Y, Danjoh I, Shimizu S, Abe J, Kawamura Y, Terashige S, Ogata H, Tatsukawa S, Yin G, Okada R, Morita E, Naito M, Tokumasu A, Onoue H, Iwaya K, Ito T, Takada T, Inoue K, Kato Y, Nakamura Y, Sakurai Y, Suzuki H, Kanai Y, Hosoya T, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N. Genome-wide association study of clinically-defined gout identifies multiple risk loci and its association with clinical subtypes. Ann Rheumatic Dis 75: 652-659, 2016.
15. Nanri H, NishidaY, Nakamura K, Tanaka K, Naito M, Yin G, Hamajima N, Takashima N, Suzuki S, Nindita Y, Kohno M, Uemura H, Kyoyama T, Hosono S, Mikami H, Kubo M, Tanaka H. Associations between dietary patterns, ADRβ2 Gln27Glu and ADRβ3 Trp64Arg with regard to serum triglyceride levels: J-MICC Study. Nutrients 8: E535, 2016.
16. Nishida Y, Hara M, Sakamoto T, Shinchi K, Kawai S, Naito M, Hamajima N, Kadota A, Suzuki S, Ibusuki R, Hirata A, Yamaguchi M, Kuriyama N, Oze I, Mikami H, Kubo M, Tanaka H, for the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group. Influence of cigarrete smoking and inflammatory gene polymorphisms on glycated hemoglobin in the Japanese general population. Prev Med Rep 3: 288-295, 2016.
17. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Upper-normal waist circumference is a risk marker for metabolic syndrome in normal-weight subjects. Nutr Metab Cardiovasc Dis 26: 67-76, 2016.
18. Pillai CPK, Yoshida Y, Lawrence PJ, Yamamoto E, Reyer JA, Hamajima N. Pediatric cardiothoracic program in Malaysia: a study based on the outcome of the program. Nagoya J Med Sci 78: 9-17, 2016.
19. Saw YM, Saw TN, Wai KM, Poudel KC, Win HH. Correlates of sex trading among male non-injecting drug users in Myanmar: a cross-sectional study. Harm Reduct J 13: 34, 2016.
20. Shimadu S, Hamajima N, Okada Y, Oguri T, Murohara T, Ban N, Sato M, Hasegawa Y. Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months. Nagoya J Med Sci 78: 205-213, 2016.
21. Sansam S, Yamamoto E, Srun S, Sinath Y, Moniborin M, Bun Sim K, Reyer JA, Yoshida Y, Hamajima N. Assessment of hand hygiene compliance after hand hygiene education among health care workers in Cambodia. Nagoya J Med Sci 78: 55-68, 2016.
22. Surenjav E, Sovd T, Yoshida Y, Yamamoto E, Reyer JA, Hamajima N. Trends in amenable mortality rate in the Mongolian population, 2007-2014. Nagoya J Med Sci 78: 55-68, 2016.
23. Suzuki K, Yamada H, Nagura A, Ohashi K, Ishikawa H, Yamazaki M, Ando Y, Ichino N, Osakabe K, Sugimoto K, Hamajima N, Inoue T. Association of cigarette smoking with serum microRNA expression in a middle-aged Japanese population. Fijita Med J 2: 1-5, 2016.
24. Wai KM, Shibanuma A, Oo NN, Fillman TJ, Saw YM, Jimba M. Correction: Are husbands involving in their spouses' utilization of maternal care services?: A cross-sectional study in Yangon, Myanmar. PLoS One 11: e0151295, 2016.
25. Yamamoto E, Niimi K, Fujikake K, Nishida T, Murata M, Mitsuma A, Ando Y, Kikkawa F. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review. Mol Clin Oncol 5: 660-664, 2016.
26. Yin G, Naito M, Wakai K, Morita E, Kawai S, Hamajima N, Suzuki Sm Kita Y, Takezaki T, Tanaka K, Morita M, Uemura H, Ozaki E, Hosono S, Mikiami H, Kubo M, Tanaka H; Japan Mulit-institutional Collaborative Cohort (J-MICC) Study Group. ALDH2 polymorphism is associated with fasting blood glucose through alcohol consumption in Japanese men. Nagoya J Med Sci 78: 183-193, 2016.
27. Yoshida Y, Harun-Or-RASHID M, Yoshida Y, Alim MA. Perceptions of Ayurvedic medicine by citizens in Dhaka, Bangladesh. Nagoya J Med Sci 78: 99-107, 2016.
28. Ushida T, Kotani T, Tsuda H, Imai K, Nakano T, Hirako S, Ito Y, Li H, Mano Y, Wang J, Miki R, Yamamoto E, Iwase A, Bando YK, Hirayama M, Ohno K, Toyokuni S, Kikkawa F. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model. Free Radic Biol Med 101: 524-533, 2016.
29. Goto A, Noto H, Noda M, Ueki K, Kasuga M, Tajima N, Ohashi K, Sakai R, Tsugane S, Hamajima N, Tajima K, Imai K, Nakagama H. Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, second report. Diabetol Int 7: 12-15, 2016.
30. Goto A, Noto H, Noda M, Ueki K, Kasuga M, Tajima N, Ohashi K, Sakai R, Tsugane S, Hamajima N, Tajima K, Imai K, Nakagama H. Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report. Cancer Sci 107: 369-371, 2016.
31. Latt NN, Cho SM, Htun NMM, Saw YM, Myin MNHA, Aoki F, Reyer JA, Yamamoto E, Yoshida Y, Hamajima N. Healthcare in Myanmar. Nagoya J Med Sci 78: 123-134, 2016.

1. Ahadi SSM, Yoshida Y, Rabi M, Sarker MA, Reyer JA, Hamajima N. Clinical features, current treatments and outcome of pregnant women with preeclampsia/eclampsia in northern Afghanisitan. Nagoya J Med Sci 77: 103-111, 2015.
2. Azimi MD, Najafizada SAM, Khaing IK, Hamajima N. Factors influencing non-institutional deliveries in Afghanistan: secondary analysis of the Afghanistan Mortality Survey 2010. Nagoya J Med Sci 77: 133-143, 2015.
3. Barmankulova A, Higuchi M, Bashar MAB, Alim AM, Hamajima N. Tuberculosis and rifampicin resistance among migrants in Kyrgyzstan: detection by a new diagnostic test. Nagoya J Med Sci 77: 41-49, 2015.
4. Chanvilay T, Yoshida Y, Reyer JA, Hamajima N, Factor associated with access to antiretroviral therapy among people living with HIV in Vientiane capital, Lao PDR. Nagoya J Med Sci 77: 29-39, 2015.
5. Hatta T, Iwahara A, Hatta T, Ito E, Hatta J, Hotta C, Nagahara N, Fujiwara K, Hamajima N. Developmental trajectories of verbal and visuospatial abilities in healthy older adults: comparison of the hemisphere asymmetry reduction in older adults model and the right hemi-aging model. Laterality 20: 69-81, 2015.
6. Higashibata T, Nakagawa H, Okada R, Wakai K, Hamajima N. Trends in smoking rates among urban civil servants in Japan according to occupational categories. Nagoya J Med Sci 77: 417-423, 2015.
7. Hosono S, Ito H, Oze I, Higaki Y, Morita E, Takashima N, Suzuki S, Shimatani K, Mikami H, Ohnaka K, Ozaki E, Katsuura-Kamano S, Kubo M, Nagata C, Naito M, Hamajima N, Tanaka H. Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group. Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese women. Maturitas 82: 394-401, 2015.
8. Ichino N, Osakab1, Sugimoto K, Suzuki K, Yamada H, Takai H, Sugiyama H, Yukitake J, Inoue T, Ohashi K, Hata T, Hamajima N, Nishikawa T, Hashimoto S, Kawabe N, Yoshioka K.. The NAFLD index: A simple and accurate screening toolforthe diagnosis ofnon-alcoholic fatty liver disease. Rinsho Byori 63: 32-43, 2015.
9. Kawai K, Naito M, Morita E, Okada R, Hishida A, Wakai K, Hamajima N. GGT1 intronic A>G polymorphism affects serum 1 concentration of gamma glutamyltransferase among Japanese healthy adults. Ningen Dock 2: 65-69, 2015.
10. Khaing IK, Malik A, Oo M, Hamajima N. Health care expenditure of households in Magway, Myanmar. Nagoya J Med Sci 77: 203-212, 2015.
11. Khammany P, Yoshida Y, Sarker MAB, Touy C, Reyer J A, Hamajima N. Delivery care satisfaction at government hospitals in Xiengkhuang province under the maternal and child health strategy in Lao PDR. Nagoya J Med Sci 77: 69-79, 2015.
12. Koyama T, Matsui D, Kuriyama N, Ozaki E, Tanaka K, Oze I, Hamajima N, Wakai K, Okada R, Arisawa K, Mikawa H, Shimatani K, Hirata A, Takashima N, Suzuki S, Nagata C, Kubo M, Tanaka H. Genetic variants of SLC17A1 are associated with cholesterol homeostasis and hyperhomocysteinemia in Japanese men. Sci Rep 5: 15888, 2015.
13. Nakashima H, Kawakami N, Tsuji T, Ohara T, Suzuki Y, Saito T, Nohara A, Tauchi R, Ohta K, Hamajima N, Imagama S. Adjacent segment disease after posterior lumbar interbody fusion: based on cases with a minimum of 10 years of follow-up. Spine 40: E831-841, 2015.
14. Nakatochi M, Ushida Y, Yasuda Y, Yoshida Y, Kawai S, Kato R, Nakashima T, Iwata M, Kuwatsuka Y, Ando M, Hamajima N, Kondo T, Oda H, Hayashi M, Kato S, Yamaguchi M, Maruyama S, Matsuo S, Honda H. Identification of novel interaction between VWF rs7965413 and platelet count for metabolic syndrome. PLoS One 10: e0117591, 2015.
15. Narin P, Hamajima N, Kouy S, Hirosawa T, Eav S. Characteristics of liver cancer at Khmer-Soviet Friendship Hospital in Phnom Penh Cambodia. Asian Pac J Cancer Prev 16: 35-39, 2015.
16. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Within-visit blood pressure variability is associated with prediabetes and diabetes. Sci Rep 5: 7964, 2015.
17. Osmani AK, Reyer JA, Osmani AR, Hamajima N. Factor influencing contraceptive use among women in Afghanistan: secondary analysis of the Afghanistan Health Survey 2012. Nagoya J Med Sci 77: 551-561, 2015.
18. Sarkar MA, Harun-Or-Rashid M, Reyer JA, Hirosaka T, Yoshida Y, Islam MM, Siddique MR, Hossain S, Sakamato J, Hamajima N. Associations of socioeconomic determinants with community clinic awareness and visitation among women: evidence from Bangladesh Demographic and Health Survey-2011. BMC Res Notes 8: 590, 2015.
19. Shahram MS, Hamajima N, Reyer JA. Factors affecting maternal healthcare utilization in Afghanistan: secondary analysis of Afghanistan Health Survey 2012. Nagoya J Med Sci 77: 595-607, 2015.
20. Sugimoto Y, Wakai K, Nakagawa H, Suma S, Sasakabe T, Sakamoto T, Takashima N, Suzuki S, Ogawa S, Ohnaka K, Kuriyama N, Arisawa K, Mikami H, Kubo M, Hosono S, Hamajima N, Tanaka H for the J-MICC Study Group. Associations between polymorphisms of interleukin-6 and related cytokine genes and serum liver damage markers: A cross-sectional study in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. Gene 557: 158-162, 2015.
21. Suma S, Naito M, Wakai K, Sasakabe T, Hattori H, Okada R, Kawai S, Hishida A, Morita E, Nakagawa H, Tamura T, Hamajima N. Effects of IL6 C-634G polymorphism on tooth loss and their interaction with smoking habits. Oral Dis 21: 807-813, 2015.
22. Suvanbekov A, Kitarova G, Reyer JA, Hamajima N. Progress toward meales elimination in Kyrgyzstan. Nagoya J Med Sci 77: 179-188, 2015.
23. Tamura T, Morita E, Kawai S, Sasakabe T, Sugimoto Y, Fukuda N, Suma S, Nakagawa H, Okada R, Hishida A, Naito M, Hamajima N, Wakai K. No association between Helicobacter pylori infection and diabetes mellitus among a general Japanese population: a cross-sectional study. SpringerPlus 4: 602, 2015.
24. Taniguchi M, Matsuo H, Shimizu S, Nakayama A, Suzuki K, Hamajima N, Shinomiya N, Nishio S, Kosugi S, Usami SI, Ito K, Kitajiri SI. Carrier frequency of GJB2 mutations that cause hereditary hearing loss in the Japanese population. J Hum Genet 60: 613-617, 2015.
25. Wai KM, Shibanuma A, Oo NN, Fillman TJ, Saw YM, Jimba M. Are husbands involving in their spouses' utilization of maternal care services? A cross-sectional study in Yangon, Myanmar. PLoS One 11:e0151295, 2015.
26. Yamaguchi M, Uemura H, Arisawa K, Katsuura-Kamano S, Hamajima N, Hishida A, Suma S, Oze I, Nakamura K, Takashima N, Suzuki S, Ibusuki R, Mikami H, Ohnaka K, Kuriyama N, Kubo M, Tanaka H for the Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group. Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: A cross-sectional analysis of the Japan Multi-Institutional Collaborative Cohort Study. Diabet Res Clin Pract 110: 301-308, 2015.
27. Katsuda N, Reyer JA, Hirosawa T, Hamajima N. Roles of public health centers (hokenjo) in tuberculosis control in Japan. Nagoya J Med Sci 77: 19-28, 2015.

1. Alim MA, Sarker MA, Selim S, Karim MR, Yoshida Y, Hamajima N. Respiratory involvements among women exposed to the smoke of traditional biomass fuel and gas fuel in a district of Bangladesh. Envrion Health Prev Med 19: 126-134, 2014.
2. Brauer HA, D'Arcy M, Libby TE, Thompson H. J, Yasui YY, Hamajima N, Li CI, Troester MA, Lampe PD. Dermcidin expression is associated with disease progression and survival among breast cancer patients. Breast Cancer Res Treat 144: 299-306, 2014.
3. Chiba T, Matsuo T, Nagamori S Nakayama A, Kawamura Y, Shimizu S, Sakiyama M, Hosoyamada M, Kawai S, Okada R, Hamajima N, Kanai Y, Shinomiya N. Identification of a hypouricemia patient with SLC2A9 R380W, a pathogenic mutation for renal hypouricemia type 2. Nucleosides Nucleotides Nucleic Acids 33: 261-265, 2014.
4. Fayaz SH, Higuchi M, Tomoya H, Sarker MAB, Djabborova Z, Hamajima N, Knowledge and practice of universal precautions among health care workers in four national hospitals in Kabul, Afghanistan. J Infect Dev Countr 4: 535-542, 2014.
5. Fukuda N, Hamajima N, Wakai K, Suzuki K. A cross-sectional study to find out the relationship of methylenetetrahydrofolate reductase (MTHFR) C677T genotype with plasma levels of folate and total homocysteine by daily folate intake in Japanese. J Nutr Sci Vitaminol (Tokyo) 60: 231-238, 2014.
6. Hara M, Nakamura K, Nanri H, Nishida Y, Hishida A, Kawai S, Hamajima N, Kita Y, Suzuki S, Mantjoro EM, Ohnaka K, Uemura H, Matsui D, Oze I, Mikami H, Kubo M, Tanaka H, on behalf of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group. Associations between hOGG1 Ser326Cys polymorphism and increased body mass index and fasting glucose in the Japanese general population. J Epidemiol 76: 379-384, 2014.
7. Hatta T, Hatta T, Hasegawa Y, Iwahara A, Ito E, Hatta J, Nagakaha N, Fujiwara K, Hotta C, Hamajima N. Developmental changes of prefrontal cortex and cerebro-cerebellar functioning in older adults: evidence from stabilometer and cognitive tests. J Aging Sci 2: 2, 2014.
8. Hatta T, Hatta T, Ito E, Iwahara A, Hatta J, Hotta C, Nagahara N, Fujiwara K, Hamajima N. Sex difference in cognitive aging for letter fluency and semantic fluency. J Women’s Health Care 3: 3, 2014.
9. Hishida A, Takashima N, Turin TC, Kawai S, Wakai K, Hamajima N, Hosono S, Nishida Y, Suzuki S, Nakahata N, Mikami H, Ohnaka K, Matsui D, Katsuura-Kamano S, Kubo M, Tanaka H, Kita Y. GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese: data from the J-MICC Study. J Nephrol 27: 143-149, 2014.
10. Hishida A , Wakai K, Naito M, Suma S, Sasakabe T, Hamajima N, Hosono S, Horita M, Turin TC, Suzuki S, Kairupan TS, Mikami H, Ohnaka K, Watanabe I, Uemura H, Kubo M, Tanaka H. Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC Study. J Lipids Health Dis 13: 162, 2014.
11. Inoue T, Suzuki K, Hamajima T, Watarai R, Kimura A, Ichino N, Kusuhara Y, Osakabe K, Sugimoto K, Yamada H, Hamajima N. Association between Helicobacter pylori infection and ABO blood groups: a cross-sectional study in Hokkaido, Japan. Int J Anal Bio-Sci 2: 72-76, 2014.
12. Katsuura-Kamano S, Uemura H, Arisawa K, Yamaguchi M, Hamajima N, Wakai K, Okada R, Suzuki S, Taguchi N, Kita Y, Ohnaka K, Kairupan TS, Matsui D, Oze I, Mikami H, Kubo M, Tanaka H for the Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group. A polymorphism near MC4R gene (rs17782313) is associated with serum triglyceride levels in the general Japanese population- the J-MICC Study. Endocrine 47: 81-89, 2014.
13. Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S, Ikeda Y, Nakahata T, Imamura M, Kawa K, Kato S, Tanimoto M, Kanda Y, Tanosaki R, Shiobara S, Kim S-W, Nagafuji K, Hino M, Miyamura K, Suzuki R, Hamajima N, Fukushima M, Tamakoshi A for the Japan Society for Hematopoietic Cell Transplantation; Halter J, Schmitz N, Niederwieser D, Gratwohl A for the European Blood and Marrow Transplant Group. PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant 49: 195-200, 2014.
14. Kono M, Nomura T, Oguchi Y, Mizuno O, Suzuki S, Tsujiuchi H, Hamajima N, McLean WHI, Shimizu H, Akiyama M. Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations. Allergy 69: 537-540, 2014.
15. Malik A, Yoshida Y, Erkin T, Salim D, Hamajima N. Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. Nagoya J Med Sci 76: 255-263, 2014.
16. Naito M, Suzukamo Y, Wakai K, Azechi M, Kaneko F, Nakayama T, Hamajima N, Fukuhara S. One-year period prevalence of oral aphthous ulcers and oral health-related quality of life in patients with Behçet's disease. Genet Res Int 2014: 930348, 2014.
17. Nakagawa H, Tamura T, Mitsuda Y, Goto Y, Kamiya Y, Kondo T, Wakai K, Hamajima N. Inverse correlation between serum interleukin-6 and iron levels among Japanese adults: a cross-sectional study. BMC Hematol 14: 6, 2014.
18. Ogawa Y, Takeichi T, Kono M, Hamajima N, Yamamoto T, Sugiura K, Akiyama M. Revertant mutation releases confined lethal mutation, opening pandora's box: a novel genetic pathogenesis. PLoS Genet 10: e1004276, 2014.
19. Sakiyama M, Matsuo H, Shimizu S, Chiba T, Nakayama A, Takada Y, Nakamura T, Takada T, Morita E, Naito M, Wakai K, Inoue H, Tatsukawa S, Sato J, Shimono K, Makino T, Satoh T, Suzuki H, Kanai Y, Hamajima N, Sakurai Y, Ichida K, Shimizu T, Shinomiya N. A common variant of leucine-rich repeat containing 16A (LRRC16A) gene is associated with gout susceptibility. Hum Cell 27: 1-4, 2014.
20. Sarker MAB, Harun-Or-Rashid M, Hirosawa T, Hai MSBA, Siddique MRF, Sakamoto J, Hamajima N. Evaluation of knowledge, practice, and possible barriers among healthcare providers regarding medical waste management in Dhaka, Bangladesh. Med Sci Monit 20: 2590-2597, 2014.
21. Shimoyama Y, Mitsuda Y, Tsuruta Y, Hamajima N, Niwa T. Polymorphism of Nrf2, an antioxidative gene, is associated with blood pressure and cardiovascular mortality in hemodialysis patients. Int J Med Sci 11: 726-731, 2014.
22. Shimoyama Y, Mitsuda Y, Hamajima N, Niwa T. Polymorphisms of Nrf2, an antioxidative gene, are associated with blood pressure in Japanese. Nagoya J Med Sci 76: 113-120, 2014.
23. Shinjo K, Yamashita Y, Yamamoto E, Akatsuka S, Uno N, Kamiya A, Niimi K, Sakaguchi Y, Nagasaka T, Takahashi T, Shibata K, Kajiyama H, Kikkawa F, Toyokuni S. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int J Cancer 135: 308-318, 2014.
24. Suma S, Naito M, Okada R, Kawai S, Yin G, Morita E, Wakai K, Matsuo H, Hamajima N. Associations between body mass index and serum uric acid levels in a Japanese population were significantly modified by Lrp2 rs2544390. Nagoya J Med Sci 76: 333-339, 2014.
25. Tamura T, Katsuda N, Hamajima N. A PCR method for VKORC1 G-1639A and CYP2C9 A1075C genotyping useful to warfarin therapy among Japanese. SpringerPlus 4: 499, 2014.
26. Tanahashi K, Sugiura K, Kono M, Takama H, Hamajima N, Akiyama M. Highly prevalent LIPH founder mutations causing autosomal recessive woolly hair/ hypotrichosis in Japan and the genotype/phenotype correlations. PLoS One 9: e89261, 2014.
27. Takashima N, Turin TC, Matsui K, Rumana N, Nakamura Y, Kadota A, Saito Y, Sugihara H, Morita Y, Ichikawa M, Hirose K, Kawakani K, Hamajima N, Miura K, Ueshima H, Kita Y. The relationship of brachial-ankle pulse wave velocity to future cardiovascular disease events in the general Japanese population: the Takashima Study. J Hum Hypert 28: 323-327, 2014.
28. Watarai R, Suzuki K, Ichino N, Osakabe K, Sugimoto K, Yamada H, Hamajima T, Hamajima N, Inoue T. Association between serum levels of carotenoids and serum asymmetric dimethylarginine levels in Japanese subjects. J Epidemiol 24: 250-257, 2014.
29. Yamamoto E, Niimi K, Shinjo K, Yamamoto T, Fukunaga M, Kikkawa F. Identification of causative pregnancy of gestational trophoblastic neoplasia diagnosed during pregnancy by short tandem repeat analysis. Gynecol Oncol Case Rep 9: 3-6, 2014.
30. Yoshida EY, Yoshida Y. Patient’s recognition level of medical terms as estimated by pharmacists. Environ Health Prev Med 19: 414-421, 2014.

1. Akao S, Tanabe K, Dorjsuren B, Higuchi M. Physical assessment ability of nurses and midwives on maternal care in Mongolia. Health 5: 475-480, 2013.
2. Beran D, Higuchi M. Delivering diabetes care in the Philippines and Vietnam: policy and practice issues. Asia Pac J Public Health 25: 92-101, 2013.
3. Chiang C, Labeeb SA, Higuchi M, Mohamed AG, Aoyama A. Barriers to the use of basic health services among women in rural southern Egypt (upper Egypt). Nagoya J Med Sci 75: 225-231, 2013.
4. Hagikura S, Wakai K, Kawai S, Goto Y, Naito M, Hagikura M, Gotoh M, Hamajima N. Association of calcium urolithiasis with urokinase P141L and 3'-UTR C>T polymorphisms in a Japanese population. Urolithiasis 41: 47-52, 2013.
5. Hamrah MS, Harun-Or- Rashid M, Hirosawa T, Sakamoto J, Hashemi H, Emamian H, Shariati M, Fotouhi A. Smoking and associated factors among population aged 40-64 in Shahroud, Iran. Asian Pac J Cancer Prev 14: 1919-1923, 2013.
6. Hatta T, Iwahara A, Hamajima N, Fujiwara K, Hotta C, Ito E, Nagahara N, Hatta T. Easy detecting signal of cognitive decline in healthy community-dwelling elderly pople. Health 5: 19-23, 2013.
7. Higashibata T, Naito M, Mori A, Ozawa N, Furuta M, Tsuchiya R, Koyama E, Morita E, Kawai S, Okada R, Yin G, Wakai K, Hamajima N. DPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC Study. Nagoya J Med Sci 75: 73-80, 2013.
8. Hinohara Y, Naito M, Okada R, Yin G, Higashibata T, Tamura T, Kawai S, Morita E, Wakai K, Matsuo H, Mori A, Hamajima N. No association between MTHFR C677T and serum uric acid levels among Japanese with ABCG2 126QQ and SLC22A12 258WW. Nagoya J Med Sci 75: 93-100, 2013.
9. Hishida A, Okada R, Guang Y, Naito M, Wakai K, Hosono S, Nakamura KK, Turin TC, Suzuki S, Niimura H, Mikami H, Otonari, J, Kuriyama N, Katsuura S, Kubo M, Tanaka H, Hamajima N. MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: corss-sectional data from the J-MICC Study. Int Urol Nephrol 45: 1613-1620, 2013.
10. Hishida A, Okada R, Naito M, Morita E, Wakai K, Hamajima N, Hosono S, Nanri H, Turin TC, Suzuki S, Kuwabara K, Mikami H, Budhathoki S, Watanabe I, Arisawa K, Kubo M, Tanaka H. Polymorphisms in genes encoding antioxidanta enzymes (SOD2 CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese -cross-sectional data from the J-MICC Study. J Clin Biochem Nutr 53: 15-20, 2013.
11. Hishida A, Wakai K, Naito M, Tamura T, Kawai S, Hamajima N, Oze I, Imaizumi T, Turin T, Suzuki S, Kheradmand M, Mikami H, Ohnaka K, Watanabe Y, Arisawa K, Kubo M, Tanaka H. Polymorphisms in PPAR genes (PPARD, PPARG and PPARGC1A) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC Study. PPAR Res 2013: 980471, 2013.
12. Hishida A, Wakai K, Okada R, Morita E, Hamajima N, Hosono S, Higaki Y, Turin TC, Suzuki S, Motahareh K, Mikami H, Tashiro N, Watanabe I, Katsuura S, Kubo M, Tanaka H, Naito M. Significant interaction between RETN -420 G/G genotype and lower BMI on decreased risk of type2 diabetes mellitus (T2DM) in Japanese  Ethe J-MICC Study. Endocr J 60: 237-243, 2013.
13. Imagama S, Ito Z, Wakao N, Seki T, Hirano K, Muramoto A, Sakai Y, Matsuyama Y, Hamajima N, Ishiguro N, Hasegawa Y. Influence of spinal sagittal alignment, body balance, muscle strength, and physical ability on falling of middle-aged and elderly males. Eur Spine J 22: 1346-1353, 2013.
14. Kamei H, Masuda S, Nakamura T, Oike F, Takada Y, Hamajima N. Association of transporter associated with antigen processing (TAP) gene polymorphisms in donors with acute cellular rejection in living donor liver transplantation. J Gastrointestin Liver Dis 22: 167-171, 2013.
15. Kamei H, Nasuda S, Nakamura T, Fujimoto Y, Oike F, Ogura Y, Takada Y, Hamajima N. Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation. Transpl Immunol 28: 14-17, 2013.
16. Kondo S, Demachi-Okamura A, Hirosawa T, Maki H, Fujita M, Uemura Y, Akatsuka Y, Yamamoto E, Shibata K, Ino K, Kikkawa F, Kuzushima K. An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 molecules. Hum Immunol 74: 1103-1110, 2013.
17. Le H, Harun-Or-Rashid M, Yoshida Y, Sakamoto J. Adverse drug reactions to antibiotics from spontaneous reporting system of Vietnam in 2007. Vietnam J Med Pharm. 3: 51-61, 2013.
18. Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T, Inoue H, Kawamura Y, Takada Y, Oikawa Y, Naito M, Hishida A, Wakai K, Utsumi Y, Nishiyama J, Niwa K, Mori A, Hamajima N, Suzuki H, Kanai Y, Sakurai Y, Hosoya T, Shimizu T, Shinomiya N. Common dysfunction of ABCG2 as a major cause of early-onset gout. Sci Rep 3: 2014, 2013.
19. Morita E, Aoyama K, Tamura T, Okada R, Kawai S, Ito Y, Naito M, Wakai K, Hamajima N. Large-scale survey of frequency of forest walking and related factors in a Japanese population inhabiting a large city and comparison of an urban area and a rural area. J Forest Res 18: 454-461, 2013.
20. Nakagawa H, Tamura T, Mitsuda Y, Kurata M, Goto Y, Kamiya Y, Kondo T, Hamajima N. Association between Helicobacter pylori infection detected by the 13C-urea breath test and low serum ferritin levels among Japanese adults. Helicobacter 18: 309-315, 2013.
21. Nakagawa H, Tamura T, Mitsuda Y, Goto Y, Kamiya Y, Kondo T, Wakai K, Hamajima N. Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori positive Japanese adults. Mediators Inflamm 2013: 142358, 2013.
22. Nakamura A, Niimura H, Kuwabara K, Takezaki T, Morita E, Wakai K, Hamajima N, Nishida Y, Turin TC, Suzuki S, Ohnaka K, Uemura H, Ozaki E, Hosono S, Mikami H, Kubo M, Tanaka H. Gene-gene combination effect and interactions among ABCA1, APOA1, SR-B1, and CETP polymorphisms for serum high-density lipoprotein-cholesterol in the Japanese population. PLoS One 8: e82046, 2013.
23. Nakashima H, Yukawa Y, Imagama S, Ito K, Hida T, Machino M, Kanbara S, Morita D, Hamajima N, Ishiguro N, Kato F. Characterizing the need for tracheostomy placement and decannulation after cervical spinal cord injury. Eur Spine J 22: 1526-1532, 2013.
24. Nakayama A, Matsuo H, Shimizu T, Ogata H, Takada Y, Nakashima H, Nakamura T, Shimizu S, Chiba T, Sakiyama M, Ushiyama C, Takada T, Inoue K, Kawai S, Hishida A, Wakai K, Hamajima N, Ichida K, Sakurai Y, Kato Y, Shimizu T, Shinomiya N. A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. Human Cell 26: 133-136, 2013.
25. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. The number of metabolic syndrome components is a good risk indicator of both early- and late-stage kidney damage. Nutr Metab Cardiovasc Dis S0939-4753, 00196-6, 2013.
26. Rodriguez PQ, Lohkamp B, Celsi G, Mache CJ, Auer-Grumbach M, Wernerson A, Hamajima N, Tryggvason K, Patrakka J. Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-Tooth neuropathy. Pediatr Nephrol 28: 339-343, 2013.
27. Sarker MA, Rahman M, Harun-Or-Rashid M, Hossain S, Kasuya H, Sakamoto J, Hamajima N.　Association of smoked and smokeless tobacco use with migraine: a hospital-based case-control study in Dhaka, Bangladesh. Tob Induc Dis 11:15, 2013.
28. Senbounsou K, Harun-Or-Rashid M, Sarker MA, Hirosawa T, Outavong P, Sakamoto J. Job satisfaction of healthcare workers at health centers in Vientiane capital and Bolikhamsai province, Lao PDR. Nagoya J Med Sci 75: 233-241, 2013.
29. Srisawang P, Harun-Or-Rashid M, Hirosawa T, Sakamoto J. Knowledge, attitudes and barriers of physicians, policy makers/regulators regarding use of opioids for cancer pain management in Thailand. Nagoya J Med Sci 75: 201-212, 2013.
30. Suzuki K, Ishii J, Kitagawa F, Kuno A, Kusuhara Y, Ochiai J, Ichino N, Osakabe K, Sugimoto K, Yamada H, Ito Y, Hamajima N, Inoue T. Association of serum carotenoid levels with N-terminal pro-brain-type natriuretic peptide: a cross-sectional study in Japan. J Epidemiol 23: 163-168, 2013.
31. Suzuki K, Honjo H, Ichino N, Osakabe K, Sugimoto K, Yamada H, Kusuhara Y, Watarai R, Hamajima T, Hamajima N, Inoue T. Association of serum carotenoid levels with urinary albumin excretion in a general Japanese population: the Yakumo study. J Epidemiol 23: 451-456, 2013.
32. Takada Y, Matsuo H, Sakiyama M, Nakayama A, Fujii A, Shimizu S, Chiba T, Ogata H, Nakashima H, Matsumura K, Suzuki K, Hamajima N, Niwa K, Sizuki S, Uchino S, Sakurai Y, Kobayashi Y, Shinomiya N. ABCG2 SNP typing using HRM assay: Effectiveness approach for gout and hyperuricemia risk evaluation. Clin Welfare J (RINSHO FUKUSHI Journal) 10: 64-69, 2013.
33. Tamura T, Morita E, Kawai S, Okada R, Naito M, Wakai K, Hori Y, Kondo T, Hamajima N. Significant association of urokinase plasminogen activator Pro141Leu with serum lipid profile in a Japanese population. Gene 524: 363-367, 2013.
34. Wakai K, Matsuo K, Matsuda F, Yamada R, Takahashi M, Kawaguchi T, Yatabe Y, Ito H, Hosono S, Tajima K, Naito M, Morita E, Yin G, Sakamoto T, Takashima N, Suzuki S, Nakahata N, Mikami H, Ohnaka K, Watanabe Y, Arisawa K, Kubo M, Hamajima N, Tanaka H for the J-MICC Study Group. Genome-wide association study of the genetic factors related to confectionery intake: potential roles of the ADIPOQ gene. Obesity 21: 2413-2419, 2013.
35. Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, Sugimoto K, Ohashi K, Teradaira R, Inoue T, Hamajima N, Hashimoto S. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta 424: 99-103, 2013.
36. Yingtaweesak T, Yoshida Y, Hemhongsa P, Hamajima N, Chaiyakae S. Accessibility of health care service in Thasongyang, Tak Province, Thailand. Nagoya J Med Sci 75: 243-250, 2013.
37. Yoshida Y, Xue D, Yoshida Y, Zhang Y, Ma D, Sato Y, Wang P. Current situation of clinical trials in Beijing and Shanghai, China. Int J Clin Pharmacol Ther 51: 433-440, 2013.
38. JDS/JCA Joint Committee on Diabetes and Cancer: Kasuga M, Ueki K, Tajima N, Noda M, Ohashi K, Imai K, Miyazono K, Tajima K, Nakagama H, Hamajima N, Tsugane S, Sakai R. Goto, Noto H, Ogawa W. Report of the JDS/JCA Joint Committee on Diabetes and Cancer. Cancer Sci 104: 965-976, 2013.

1. Aimukhametova G, Ukybasova T, Hamidullina Z, Zhubanysheva K, Harun-Or-Rashid M, Yoshida Y, Kasuya H, Sakamoto J. The impact of maternal obesity on mother and neonatal health: study in a tertiary hospital of Astana, Kazakhstan. Nagoya J Med Sci 74: 83-92, 2012.
2. De Feo E, Simone B, Kamgaing RS, Galli P, Hamajima N, Hu Z, Li G, Li Y, Matsuo K, Park JY, Roychoudhury S, Spitz MR, We Q, Zhang JH, Ricciardi W, Boccia S. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. Mutagenesis 27: 267-273, 2012.
3. Gochi A, Saji S, Sakamoto J, Hirata K, Tominaga S, Yamaguchi Y, Shibata M, Kai Y, Tanemura H, Shirasaka T. A Phase III study of combination therapy of the oral fluorinated pyrimidine compound tegafur-uracil (UFT) with low dose cisplatin compared with UFT alone in patients with locally advanced gastric cancer as postoperative adjuvant chemotherapy. Ann Cancer Res Therap 20: 17-23, 2012.
4. Goto Y, Kato T, Ando T, Goto H, Hamajima N. No association between the CDX2 G543C polymorphism and risk of gastric atrophy and cancer. Asian Pac J Cancer Prev 13: 5691-5694, 2012.
5. Hamajima N, Naito M, Okada R, Kawai S, Yin G, Morita E, Higashibata T, Tamura T, Nakagawa H, Matsuo H, Mori A, Wakai K. Significant interaction between LRP2 rs2544390 in intron 1 and alcohol drinking for serum uric acid levels among a Japanese population. Gene 503:131-136, 2012.
6. Hara M, Higaki Y, Taguchi N, Shinchi K, Morita E, Naito M, Hamajima N, Takashima N, Suzuki S, Nakamura A, Ohnaka K, Uemura H, Nishida H, Hosono S, Mikami H, Kubo M, Tanaka H, on behalf of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group. Effect of PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c levels in the Japanese general population. J Epidemiol 22: 523-531, 2012.
7. Higashibata T, Hamajima N, Naito M, Kawai S, Yin G, Suzuki S, Kita Y, Niimura H, Imaizumi T, Ohnaka K, Arisawa K, Shigeta M, Ito H, Mikami H, Kubo M, Tanaka H, Wakai K. eNOS genotype modifies the effect of leisure-time physical activity on serum triglyceride levels in a Japanese population. Lipids Health Dis 11: 150, 2012.
8. Hishida A, Morita E, Naito M, Okada R, Wakai K, Matsuo K, Nakamura K, Takashima N, Suzuki S, Takezaki T, Mikami H, Ohnaka K, Watanabe Y, Uemura H, Kubo M, Tanaka H, Hamajima N. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study. Endocr J 59: 589-599, 2012.
9. Hiyoshi M, Uemura H, Arisawa K, Nakamoto M, Hishida A, Okada R, Kita Y, Niimura H, Kuriyama N, Nanri H, Ohnaka K, Suzuki S, Mikami H, Kubo M, Tanaka H, Hamajima N, for the J-MICC Study Group. Association between the catechol-O-methyltransferase (rs4680: Val158Met) polymorphism and serum alanine aminotransferase activity. Gene 496: 97-102, 2012.
10. Ichino N, Osakabe K, Sugimoto K, Yokoi A, Inoue T, Suzuki K, Kusuhara Y, Hamajima N, Nishikawa T, Takai H, Hata T. The stiffness parameter β assessed by an ultrasonic phase-locked echo-tracking system is associated with plaque formation in the common carotid artery. J Med Ultrasonic 39: 3-9, 2012.
11. Imagama S, Hasegawa Y, Wakao N, Hirano K, Hamajima N, Ishiguro N. Influence of lumber kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people. Eur Spine J 21: 2149-2157, 2012.
12. Jumayev I, Harun-Or-Rashid M, Rustamov O, Zakirova N, Kasuya H, Sakamoto J. Social correlates of female infertility in Uzabekistan. Nagoya J Med Sci 74: 273-283, 2012.
13. Kawai S, Oba-Shinjo SM, Ito LS, Uno M, Marie SK, Hamajima N. Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study. BMC Clin Pathol 12: 23, 2012.
14. Khandarmaa TO, Harun-Or-Rashid M, Sakamoto J. Risk factors of burns among children in Mongolia. Burns 38: 751-757, 2012.
15. Khun M, Heng C, Md HO, Kasuya H, Sakamoto J. Knowledge, attitudes and practices towards avian influenza A (H5N1) among Cambodian women: a cross-sectional study. Asian Pac J Trop Med 5: 727-734, 2012.
16. Kobayashi M, Hazama S, Takahashi K, Oba K, Okayama N, Nishioka M, Hinoda Y, Oka M, Okamoto K, Maeda H, Nakamura D, Sakamoto J, Mishima H. Is there diversity among UGT1A1 polymorphism in Japan? World J Gastrointest Oncol 4: 170-175, 2012.
17. Kulkayeva G, Harun-Or-Rashid M, Yoshida Y, Tulebayev K, Sakamoto J. Cardiovascular disease risk factors among rural Kazakh population. Nagoya J Med Sci 74: 51-61, 2012.
18. Mishima H, Oba K, Sakamoto J, Muro K, Yoshino T, Hyodo I, Maehara Y. FOLFIRI plus bevacizumab 5 mg/kg versus 10 mg/kg as second-line therapy in patients with metastatic colorectal cancer who have failed first-line bevacizumab plus oxaliplatin-based therapy: a randomized phase III study (EAGLE Study). Jpn J Clin Oncol 42: 134-138, 2012.
19. Naito M, Asai Y, Mori A, Fukada Y, Kuwabara M, Katase S, Hishida A, Morita E, Kawai S, Okada R, Nishio K, Tamakoshi A, Wakai K, Hamajima N. Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese men. Nagoya J Med Sci 74: 285-292, 2012.
20. Nakashima H, Imagama S, Yukawa Y, Kanemura T, Kamiya M, Yanase M, Ito K, Machino M, Yoshida G, Ishikawa Y, Matsuyama Y, Hamajima N, Ishiguro N, Kato F. Multivariate analysis of C5 palsy incidence after cervical posterior fusion with instrumentation. J Neurosurg Spine17: 103-110, 2012.
21. Nishiguchi KM, Yasuma TR, Tomida D, Nakamura M, Ishikawa K, Kikuchi M, Niwa T, Hamajima N, Terasaki H. C9-R95X polymorphism in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 53: 508-518, 2012.
22. Nishikawa K, Morita S, Matsui T, Kobayashi M, Takeuchi Y, Takahashi I, Sato S, Miyashita Y, Tsuburaya A, Sakamoto J, Kakeji Y, Baba H. A randomized phase II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer. Gastric Cancer 15: 363-369, 2012.
23. Nishio N, Fujita M, Tanaka Y, Maki H, Zhang R, Hirosawa T, Demachi-Okamura A, Uemura Y, Taguchi O, Takahashi Y, Kojima S, Kuzushima K. Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells. J Immunother 35: 598-606, 2012.
24. Nishiyama T, Kishino H, Suzuki S, Ando R, Niimura H, Uemura H, Horita M, Ohnaka K, Kuriyama N, Mikami H, Takashima N, Mastuo K, Guang Y, Wakai K, Hamajima N, Tanaka H, for the J-MICC Study Group. Detailed analysis of Japanese population substructure with a focus on the Southwest Islands of Japan. PLoS One 7: e35000, 2012.
25. Nobata S, Hishida A, Naito M, Asai Y, Mori A, Kuwabara M, Katase S, Okada R, Morita E, Kawai S, Hamajima N, Wakai K. Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men. Urol Int 89: 39-44, 2012.
26. Okada R, Kawai S, Naito M, Hishida A, Hamajima N, Shinchi K, Turin TC, Suzuki S, Mantjoro EM, Toyomura K, Arisawa K, Kuriyama N, Hosono S, Mikami H, Kubo M, Tanaka H, Wakai K. The Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group. Matrix metalloproteinase-9 gene polymorphisms and chronic kidney disease. Am J Nephrol 36: 444-450, 2012.
27. Okada R, Okada T, Okada A, Muramoto H, Katsuno M, Sobue G, Hamaijma N. Severe brain atrophy in the elderly as a risk factor for lower respiratory tract infection. Clin Interv Aging 7: 481-487, 2012.
28. Okada R, Wakai K, Naito M, Morita E, Kawai S, Hamajima N, Hara M, Takashima N, Suzuki S, Takezaki T, Ohnaka K, Arisawa K, Hirohata H, Matsuo K, Mikami H, Kubo M, Tanaka H. Pro/anti-inflammatory cytokine gene polymorphisms and chronic kidney disease: a cross-sectional study. BMC Nephrol 13: 2, 2012.
29. Okada R, Wakai K, Naito M, Morita E, Kawai S, Yin G, Ozawa N, Furuta M, Koyama E, Tsuchiya R, Kouno N, Hamajima N. Renal hyperfiltration in prediabetes confirmed by fasting plasma glucose and hemoglobin A1c. Ren Fail 34: 1084-1090, 2012.
30. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 27: 1821-1825, 2012.
31. Piotrowski J, Harun-Or-Rashid M, Hirosawa T, Sakamoto J. Evaluation of the national breast cancer screening program in Poland in 1999-2009. National Cancer Registry Overview. Ann Cancer Res Ther 20: 39-46, 2012.
32. Pulatova G, Harun-Or-Rashid M, Yoshida Y, Sakamoto J. Elderly health and its correlations among Uzbek population. Nagoya J Med Sci 74: 71-82, 2012.
33. Saika K, Sobue T, Nakamura M, Oshima A, Wakabayashi K, Hamajima N, Mochizuki Y, Yamaguchi R, Tajima K. Smoking prevalence and beliefs on smoking cessation among members of the Japanese Cancer Association in 2006 and 2010. Cancer Sci 103: 1595-1599, 2012.
34. Sakamoto J, Oba K. Geographic difference in advanced gastric cancer prevalence and chemotherapy treatment results: could it really be an independent prognostic factor? Gastric Cancer 15: 232-234, 2012.
35. Sarker M, Harun-Or-Rashid M, Hirosawa T, Siddique R, Talukder H, Islam J, Sakamoto J. Trends and distributions of common types of cancer in Bangladesh: Results from the cancer registry data of 2008-10. Ann Cancer Res Ther 20: 32-38, 2012.
36. Shimoyama Y, Mitsuda Y, Tsuruta Y, Suzuki K, Hamajima N, Niwa T. SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. J Ren Nutr 22: 114-119, 2012.
37. Shitara K, Morita S, Fujitani K, Kadowaki S, Takiguchi N, Hirabayashi N, Takahashi M, Takagi M, Tokunaga Y, Fukushima R, Munakata Y, Nishikawa K, Takagane A, Tanaka T, Sekishita Y, Sakamoto J, Tsuburaya A. Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis. Gastric Cancer 15: 245-251, 2012.
38. Sone M, Katayama N, Kato T, Izawa K, Wada M, Hamajima N, Nakashima T. Prevalence of laryngopharyngeal reflux symptoms: comparison between health checkup examinees and patients with otitis media. Otolaryngol Head Neck Surg 146: 562-566, 2012.
39. Tamura T, Morita E, Kondo T, Ueyama J, Tanaka T, Kida Y, Hori Y, Inoue S, Tomita K, Okada R, Kawai S, Hishida A, Naito M, Wakai K, Hamajima N. Prevalence of Helicobacter pylori infection measured with urinary antibody in an urban area of Japan, 2008-2010. Nagoya J Med Sci 74: 63-70, 2012.
40. Tamura T, Kurata M, Kondo T, Goto Y, Kamiya Y, Kawai S, Mitsuda Y, Hamajima N. Preventive medical services uncovered by public health insurance at Daiko Medical Center in Japan, 2004-2011. Nagoya J Med Sci 74: 115-121, 2012.
41. Thu TA, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung NV. Antibiotic use in Vietnamese hospitals: A multicenter point-prevalence study. Am J Infect Control 40: 840-844, 2012.
42. Trinh D. T, Shibata K, Hirosawa T, Umezu T, Mizuno M, Kajiyama H, Kikkawa F. HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. J Obstet Gynaecol Res 38: 841-845, 2012.
43. Tsuburaya A, Morita S, Kodera Y, Kobayashi M, Shitara K, Yamaguchi K, Yoshikawa T, Yoshida K, Yoshino S, Sakamoto J. A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II). BMC Cancer 12: 307, 2012.
44. Uemura H, Hiyoshi M, Arisawa K, Yamaguchi M, Naito M, Kawai S, Hamajima N, Matsuo K, Taguchi N, Takashima N, Suzuki S, Hirasada K, Mikami H, Ohnaka K, Yoshikawa A, Kubo M, Tanaka H. Gene varients in PPARD and PPARGC1A are associated with timing of natural menopause in the general Japanese population. Maruritas 71: 369-375, 2012.
45. Watanabe T, Yoshikawa T, Kameda Y, Aoyama T, Hayashi T, Ogata T, Cho H, Tsuburaya A, Morita S, Miyashita Y, Sakamoto J. Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case. Surg Today 42: 983-987, 2012.
46. Yamamoto TS, Sunguya BF, Shiao LW, Amiya RM, Saw YM, Jimba M. Migration of health workers in the Pacific Islands: a bottleneck to health development. Asia Pac J Public Health 24; 697-709, 2012.
47. Yamamura T, Hikita J, Bleakley M, Hirosawa T, Sato-Otsubo A, Torikai H, Hamajima T, Nannya Y, Demachi-Okamura A, Maruya E, Saji H, Yamamoto Y. Takahashi T, Emi N, Morishima Y, Kodera Y, Kuzushima K, Riddell SR, Ogawa S, Akatsuka Y. HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. Tissue Antigens 80: 119-125, 2012.
48. Yin G, Morita M, Ohnaka K, Toyomura K, Hamajima N, Mizoue T, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Terasaka R. Genetic polymorphisms of XRCC1, alcohol consumption and risk of colorectal cancer in Japan. J Epidemiol 22: 64-71, 2012.
49. Yoshida C, Fletcher L, Ohashi K, Wakita H, Kumagai T, Shiseki M, Matsuei K, Inokuchi K, Hatta Y, Shirasugi Y, Yamaguchi T, Sakamoto J, Branford S, Sakamaki H. Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan. Int J Clin Oncol 17: 584-589, 2012.
50. Yoshimoto M, Takao S, Hirata M, Okamoto Y, Yamashita S, Kawaguchi Y, Takami M, Furusawa H, Morita S, Abe C, Sakamoto J. Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer. Cancer Chemother Pharmacol 70: 331-338, 2012.
51. Yoshida Y, Zhang Y, Yoshida Y, Ma D, Wang P. Current situation of clinical trials in Beijing, China. Contemp Clin Trials 33: 583-588, 2012.

1. Abdiev S, Kodera Y, Fujiwara M, Koike M, Nakayama G, Ohashi N, Tanaka C, Sakamoto J, Nakao A. Nutritional recovery after open and laparoscopic gastrectomies. Gastric Cancer 14: 144-149, 2011.
2. Dao HH, Do QT, Sakamoto J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology (Oxford) 50: 1250-1258, 2011.
3. Dao HH, Do QT, Sakamoto J. Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis. Clin Rheumatol 30: 1353-1361, 2011.
4. Hamada C, Sakamoto J, Satoh T, Sadahiro S, Mishima H, Sugihara K, Saji S, Tomita N. Does 1 year adjuvant chemotherapy with oral 5-FUs in colon cancer reduce the peak of recurrence in 1 year and provide long-term OS benefit? Jpn J Clin Oncol 41: 299-302, 2011.
5. Hara T, Nishikawa K, Sakatoku M, Oba K, Sakamoto J, Omura K. Phase II study of weekly paclitaxel, cisplatin and 5-fluorouracil for advanced gastric cancer. Gastric Cancer 14: 332-338, 2011.
6. Harun-Or-Rashid M, Yoshida Y, Rashid MA, Nuhar S, Sakamoto J. Perceptions of the Muslim religious leaders and their attitudes on herbal medicine in Bangladesh: a cross-sectional study. BMC Res Notes 366: 1-9, 2011.
7. Imamoto H, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, Morimoto T, Nakamura M, Oriuchi N, Kakutani C, Morita S, Shiozaki H. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer 14: 81-90, 2011.
8. Baktygul K, Marat B, Ashirali Z, Harun-Or-Rashid M, Sakamoto J. An assessment of antibiotics prescribed at the secondary health-care level in the Kyrgyz Republic. Nagoya J Med Sci 73: 157-168, 2011.
9. Kato T, Nagata N, Fujii M, Takemoto H, Kondo K, Okuyama Y, Tominaga H, Sakamoto J, Mishima H. Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 study. Anticancer Res 31: 4657-4664, 2011.
10. Kodera Y, Imano M, Yoshikawa T, Takahashi N, Tsuburaya A, Miyashita Y, Morita S, Nakao A, Sakamoto J, Sasako M. A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). Jpn J Clin Oncol 41: 283-286, 2011.
11. Komatsu Y, Takahashi Y, Kimura Y, Oda H, Tajima Y, Tamura S, Sakurai J, Wakasugi T, Tatebe S, Takahashi M, Sakata Y, Kitajima M, Sakamoto J, Saji S. Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301). Anticancer Drugs 22: 576-583, 2011.
12. Mamarajabov S, Kodera Y, Karimov S, Abdiev S, Sabirov B, Krotov N, Kurbaniyazov Z, Arziev I, Sattarov S, Fayziev T, Yoshida Y, Nakao A, Sakamoto J. Surgical alternatives for hepatic hydatid disease. Hepatogastroenterology 58: 1859-1861, 2011.
13. Musa MB, Fariza MY, Harun-Or-Rashid M, Sakamoto J. Cancers affecting women in Malaysia. Ann Cancer Res Ther 19: 20-25, 2011.
14. Musa MB, Harun-Or-Rashid M, Sakamoto J. Nurse managers' experience with ethical issues in six government hospitals in Malaysia: a cross-sectional study. BMC Med Ethics 12: 23, 2011.
15. Nakayama T, Morita S, Takashima T, Kamigaki S, Yoshidome K, Ito T, Taguchi T, Sakamoto J, Noguchi S. Phase I study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer. Anticancer Res 31: 3035-3039, 2011.
16. Oba K, Matsuoka M, Satoh T, Muro K, Oriuchi N, Sakamoto J, Mishima H. Multicentre phase II study of XELOX with bevacizumab in late-stage elderly patients with unresectable advanced/recurrent colorectal cancer: an ASCA study. Jpn J Clin Oncol 41: 134-138, 2011.
17. Okuyama Y, Hazama S, Nozawa H, Kobayashi M, Takahashi K, Fujikawa K, Kato T, Nagata N, Kimura H, Oba K, Sakamoto J, Mishima H. Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms. Jpn J Clin Oncol 41: 477-482, 2011.
18. Ongoagchai S, Harun-Or-Rashid M, Sakamoto J. Factors affecting drug quality problems in Thailand. Qual Assur J 14: 9 -17, 2011.
19. Thu TA, Hung NV, Quang NN, Archibald LK, Thuy le TT, Harun-Or-Rashid M, Sakamoto J. A point-prevalence study on healthcare-associated infections in Vietnam: public health implications. Infect Control Hosp Epidemiol 32: 1039-1041, 2011.
20. Widsanugorn O, Suwattana O, Harun-Or-Rashid M, Sakamoto J. Healthcare workers' knowledge and practices regarding expanded program on immunization in Kalasin, Thailand. Nagoya J Med Sci 73: 177-185, 2011.

1. Abdiev S, Ahn KS, Khadjibaev A, Malikov Y, Bahramov S, Rakhimov B, Sakamoto J, Kodera Y, Nakao A, Hamajima N. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks. Nagoya J Med Sci 72: 167-172, 2010.
2. Baizhumanova A, Nishimura A, Ito K, Sakamoto J, Karsybekova N, Tsoi I, Hamajima N. Effectiveness of communication campaign on iron deficiency anemia in Kyzyl-Orda region, Kazakhstan: a pilot study. BMC Blood Disord 17: 10, 2010.
3. Baizhumanova A, Sakamoto J. Cancer in Kazakhstan: Present situation on Cancer Ann. Cancer Res Therap 18: 65-68, 2010.
4. Dao HH, Do QT, Sakamoto J. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 12: R218, 2010.
5. Dao HH, Harun-Or-Rashid M, Sakamoto J. Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford) 49: 2400 -2407, 2010.
6. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303: 1729-1737, 2010.
7. Harun-Or-Rashid M, Asai M, Sun XY, Hayashi Y, Sakamoto J, Murata Y. Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice. Thyroid Res 3: 3, 2010.
8. Heng LS, Yatsuya H, Morita S, Sakamoto J. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis. J Epidemiol 20: 70-76, 2010.
9. Htay SS, Oo M, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Risk behaviours and associated factors among medical students and community youths in Myanmar. Nagoya J Med Sci 72: 71-81, 2010.
10. Kodera Y, Ishiyama A, Yoshikawa T, Kinoshita T, Ito S, Yokoyama H, Mochizuki Y, Ito H, Tsuburaya A, Sakamoto J, Nakao A, Chubu Clinical Cancer Group. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer 13: 197-203, 2010.
11. Masuda N, Nakayama T, Yamamura J, Kamigaki S, Taguchi T, Hatta M, Sakamoto J. Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer. Cancer Chemother Pharmacol 66: 89-94, 2010.
12. Nakata B, Tsuji A, Mitachi Y, Taenaka N, Kamano T, Oikawa K, Onoda N, Kambe M, Takahashi M, Shirasaka T, Morita S, Sakamoto J, Tanaka Y, Saji S, Hirakawa K. Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2). Oncology 79: 337-342, 2010.
13. Oji Y, Oka Y, Nishida S, Tsuboi A, Kawakami M, Shirakata T, Takahashi K, Murao A, Nakajima H, Narita M, Takahashi M, Morita S, Sakamoto J, Tanaka T, Kawase I, Hosen N, Sugiyama H. WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient. Eur J Haematol 85: 358-360, 2010.
14. Rakchanok N, Amporn D, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Dental caries and gingivitis among pregnant and non-pregnant women in Chiang Mai, Thailand. Nagoya J Med Sci 72: 43-50, 2010.
15. Taguchi T, Nakayama T, Masuda N, Yoshidome K, Akagi K, Nishida Y, Yoshikawa Y, Ogino N, Abe C, Sakamoto J, Noguchi S, Kinki Breast Cancer Study Group. Study of low-dose capecitabine monotherapy for metastatic breast cancer. Chemotherapy 56: 166-170, 2010.
16. Ueda Y, Yamagishi H, Ichikawa D, Okamoto K, Otsuji E, Morii J, Koizumi K, Kakihara N, Shimotsuma M, Yamashita T, Taniguchi F, Aragane H, Nishi H, Itokawa Y, Morita S, Sakamoto J. Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer. Gastric Cancer 13: 149-154, 2010.
17. Viengsakhone L, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Factors affecting low birth weight at four central hospitals in Vientiane, Lao PDR. Nagoya J Med Sci 72: 51-58, 2010.
18. Ye Y, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Factors affecting the utilization of antenatal care services among women in Kham District, Xiengkhouang province, Lao PDR. Nagoya J Med Sci 72: 23-33, 2010.
19. Yoshida Y, Omori T, Sakamoto J, Arizono K. How to present the monitoring data of tributyl-tin compounds (TBT) and trans-chlordane in sediment of Japan. Nagoya Med J 51: 133-143, 2010.
20. Yoshikawa T, Tsuburaya A, Morita S, Kodera Y, Ito S, Cho H, Miyashita Y, Sakamoto J. A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized phase II trial (COMPASS). Jpn J Clin Oncol 40: 369-372, 2010.

1. Bayarmaa C, Ganbold L, Sakamoto J, Hamajima N. Disaster and emergency preparedness of hospitals in Mongolia. Southeast Asian J Trop Med Public Health 40 (Suppl 1): 16-22, 2009.
2. Guo L, Jiang Y, Yatsuya H, Yoshida Y, Sakamoto J. Group education with personal rehabilitation for idiopathic Parkinson's disease. Can J Neurol Sci 36: 51-59, 2009.
3. Harun-Or-Rashid M, Khatun UF, Yoshida Y, Morita S, Chowdhury N, Sakamoto J. Iron and iodine deficiencies among under-2 children, adolescent girls and pregnant women of Bangladesh: association with common diseases. Nagoya J Med Sci 71: 39-49, 2009.
4. Kono T, Mishima H, Shimada M, Morita S, Sakamoto J, for the GONE investigators. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: A placebo-controlled double-blind randomized phase II study (the GONE Study). Jpn J Clin Oncol 40: 369-372, 2009.
5. Maeda Y, Sakamoto J, Wang SY, Mizuno Y. Lower critical solution temperature behavior of poly (N-(2-ethoxyethyl)acrylamide) as compared with poly (N-isopropylacrylamide). J Phys Chem B 113: 12456-12461, 2009.
6. Matsui T, Kojima T, Kojima H, Iwamoto N, Kure S, Uemura T, Fujimitsu Y, Sakamoto J. Feasibility study of direct fentanyl patch introduction without prior opioid titration. Int J Clin Oncol 14: 202-207, 2009.
7. Nalongsack S, Yoshida Y, Morita S, Sosouphanh K, Sakamoto J. Knowledge, attitude and practice regarding dengue among people in Pakse, Laos. Nagoya J Med Sci 71: 29-37, 2009.
8. Oba K, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res 29: 2739-2745, 2009.
9. Yoshikawa T, Tsuburaya A, Hirabayashi N, Yoshida K, Nagata N, Kodera Y, Takahashi N, Oba K, Kimura M, Ishikura S, Miyashita Y, Sakamoto J. A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma. Cancer Chemother Pharmacol 64: 1071-1077, 2009.
10. Sakamoto J, Matsui T, Kodera Y. Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer 12: 69-78, 2009.
11. Sakamoto J, Implementation and limitations of meta-analysis of randomized trials from the clinical biostatistician's point of view. Int J Clin Oncol 14: 83-84, 2009.

1. Burzykowski T, Buyse M, Yothers G, Sakamoto J, Sargent D. Exploring and validating surrogate endpoints in colorectal cancer. Lifetime Date Anal 14: 54-64, 2008.
2. Cho H, Tsuburaya A, Sakamoto J, Morita S, Oba K, Yoshikawa T, Miyajima N. A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: Adjuvant Exercise for General Elective Surgery (AEGES) Study Group. Jpn J Clin Oncol 38: 71-73, 2008.
3. Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, Hashimoto N, Maruno M, Elisseeva OA, Shirakata T, Kawakami M, Oji Y, Nishida S, Ohno S, Kawase I, Hatazawa J, Nakatsuka S, Aozasa K, Morita S, Sakamoto J, Sugiyama H, Yoshimine T. Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg 108: 963-971, 2008.
4. Kato T, Mishima H, Ikenaga M, Murata K, Ishida H, Fukunaga M, Ota H, Tominaga S, Ohnishi T, Amano M, Ikeda K, Ikeda M, Sekimoto M, Sakamoto J, Monden M. A Phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer. Cancer Chemother Pharmacol 61: 275-281, 2008.
5. Koizumi W, Okayasu I, Hyodo I, Sakamoto J, Kojima H. Clinical Study Group of Capecitabine. Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase. Anticancer Drugs 19: 819-824, 2008.
6. Masuda N, Taguchi T, Nakayama T, Shiba E, Watatani M, Kurebayashi J, Takatsuka Y, Sakamoto J, Noguchi S, Kinki Breast Cancer Study Group (KBCSG). Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group. Cancer Chemother Pharmacol 61: 989-995, 2008.
7. Morita S, Kaptein A A, Oba K, Sakamoto J. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. Psycho-Oncology 17: 474-479, 2008.
8. Nagata N, Kimura M, Hirabayashi N, Tuburaya A, Murata T, Kondo K, Fukuda Y, Kobayashi M, Miyashita Y, Nakao A, Sakamoto J. Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer. Hepatogastroenterology 55: 1846-1850, 2008.
9. Nakajo A, Hokita S, Ishigami S, Miyazono F, Etoh T, Hamanoue M, Maenohara S, Iwashita T, Komatsu H, Satoh K, Aridome K, Morita S, Natsugoe S, Takiuchi H, Nakano S, Maehara Y, Sakamoto J, Aikou T, Kyushu Taxol TS-1 Study Group. A multicenter phase -II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer. Cancer Chemother Pharmacol 62: 1103-1109, 2008.
10. Nguyen TL, Nguyen TH, Morita S, Sakamoto J. Injury and pre-hospital trauma care in Hanoi, Vietnam. Injury 39: 1026-1033, 2008.

1. Enkhbold S, Tugsdelger S, Morita S, Sakamoto J, Hamajima N. HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. Nagoya J Med Sci 69: 157-165, 2007.
2. Hara T, Omura K, Hirano M, Asada Y, Munemoto Y, Sakamoto J. A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer. Cancer Chemother Pharmacol 59: 631-636, 2007.
3. Kawakami M, Oka Y, Tsuboi A, Harada Y, Elisseeva OA, Furukawa Y, Tsukaguchi M, Shirakata T, Nishida S, Nakajima H, Morita S, Sakamoto J, Kawase I, Oji Y, Sugiyama H. Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5µg/body) in a patient with chronic myelomonocytic leukemia. Int J Hematol 85: 426-429, 2007.
4. Kim Y H, Yamaguchi K, Bang Y, Takiuchi H, Kag W K, Sato A, Kang Y, Sakamoto J, Abe C, Sakata Y. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial. Jpn J Clin Oncol 37: 501-508, 2007.
5. Kobayashi M, Oba K, Sakamoto J, Kondo K, Nagata N, Okabayashi T, Namikawa T, Hanazaki K. Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan. Gastric Cancer 10: 52-57, 2007.
6. Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Kitagawa H, Hokimoto N, Okabayashi T. Hanazaki K. Modified funada’s gastropexy needle for mesh fixation in the subcutaneous layer using thread during laparoscopic incisional hernia repair. Surg Laparosc Endosc Percutan Tech 17: 296-299, 2007.
7. Kodera Y, Ito S, Mochizuki Y, Fujitake S, Koshikawa K, Kanyama Y, Matsui T, Kojima H, Takase T, Ohashi N, Fujiwara M, Sakamoto J, Nakao A, Chubu Clinical Cancer Group. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 Study). Anticancer Res 27: 2667-2672, 2007.
8. Kurita M, Shimozuma K, Morita S, Fujiki Y, Ishizawa K, Eguchi H, Saito Y, Ushiorozawa N, Wasada I, Ohashi Y, Eguchi K. Clinical Validity of the Japanese Version of the Functional Assessment of Cancer Therapy-Anemia Scale. Support Care Cancer 15: 1-6, 2007.
9. Morita S, Baba H, Tsuburaya A, Takiuchi H, Matsui T, Maehara Y, Sakamoto J. A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC). Jpn J Clin Oncol 37: 469-472, 2007.
10. Morita S, Nakata B, Tsuji A, Mitachi Y, Shirasaka T, Saji S, Ohashi Y, Sakamoto J, Hirakawa K. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method. Jpn J Clin Oncol 37: 924-929, 2007.
11. Morita S, Toi M, Saji S, Iwata H, Ohno S, Ito Y, Kobayashi T, Hozumi Y, Sakamoto J. Practical application of the Continual Reassessment Method to a phase I dose-finding trial in advanced breast cancer. Drug Information J 41: 691-700, 2007.
12. Ninomiya M, Kondo K, Matsuo K, Hirabayashi N, Kojima H, Kobayashi M, Kawamura S, Ando T, Musha N, Miyashita K, Konno H, Nagata N, Saito N, Usuki H, Ozaki N, Nonaka Y, Iwashita T, Miyashita Y, Oba K, Morita S, Sakamoto J. Multicenter Phase II Trial of Combination Chemotherapy with Weekly Paclitaxel and 5-Fluorouracil for the Treatment of Advanced or Recurrent Gastric Carcinoma. J Chemother 19: 444-450, 2007.
13. Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother 56: 905-911, 2007.
14. Rahman M, Nurullah Awal AS, Fukui T, Sakamoto J. Prevalence of cigarette and bidi smoking among rickshaw pullers in Dhaka city. Prev Med 44: 218-222, 2007.
15. Saji S, Toi M, Morita S, Iwata H, Ito Y, Ohno S, Kobayashi T, Hozumi Y, Sakamoto J. Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophoshamide (CEX) in patients with inoperable or metastatic breast cancer. Oncology 72: 330-337, 2007.
16. Sakamoto J, Hamada C, Yoshida S, Kodaira S, Yasutomi M, Kato T, Oba K, Nakazato H, Saji S, Ohashi Y. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected cancer. Br J Cancer 96: 1170-1177, 2007.
17. Sakamoto J, Morita S. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside Nagoya J Med Sci 69: 9-16, 2007.
18. Tsuboi A, Oka Y, Nakajima H, Fukuda Y, Elisseeva OA, Yoshihara S, Hosen N, Ogata A, Kito K, Fujiki F, Nishida S, Shirakata T, Ohno S, Yasukawa M, Oji Y, Kawakami M, Morita S, Sakamoto J, Udaka K, Kawase I, Sugiyama H. Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma. Int J Hematol. 86: 414-417, 2007.
19. Urushihara H, Fukuhara S, Tai S, Morita S, Chihara K. Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with growth hormone deficiency during GH replacement. Eur J Endocrinol 156: 637-645, 2007.
20. Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, Kasuya H, Kodera Y, Nagasaka T, Morita S, Nakao A. Clinical Implications of Peritoneal Cytology in Potentially Resectable Pancreatic Cancer: Positive Peritoneal Cytology May Not Confer an Adverse Prognosis. Ann Surg 246: 254-258, 2007.
21. Yamazaki S, Fukuhara S, Suzukamo Y, Morita S, Okamura T, Tanaka T, Ueshima H. Lifestyle and work predictors of fatigue in Japanese manufacturing workers. Occup Med (Lond) 57: 262-269, 2007.
22. Sakamoto J, Morita S. From translational research to a large randomized clinical trial: A long and streanuous way form bench to bedside. Nagoya J Med Sci 69: 9-16, 2007.

1. Ando K, Morita S, Higashi T, Fukuhara S, Watanabe S, Park S, Kikuchi M, Kawano K, Wasada I, Hotta T. Health-related quality of life among asymptomatic women with iron-deficiency anemia in Japan. Quality Life Res 15: 1559-1563, 2006.
2. Baigalmaa D, Nishimura A, Ito K. Smoking cessation rate 12 months after a group counseling program in Mongolia. Asian Pac J Cancer Prev 7: 399-402, 2006.
3. Chen XY, Yamauchi K, Kato K, Nishimura A, Ito K. Using the balanced scorecard to measure Chinese and Japanese hospital performance. Int J Health Care Qual Assur Inc Leadersh Health Serv 19: 339-350, 2006.
4. Fujiwara M, Kodera Y, Kasai Y, Miura S, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopy-assisted total gastrectomy for a case of MALT lymphoma: a case report. Hepatogastroenterology 53: 648-650, 2006.
5. Fukui T, Rahman M, Morita S, Sakamoto J. Informed consent in the Candesartan Antihypertensive survival Evaluation in Japan (CASE-J) trial: A survey of collaborating physicians. Hypertens Res 29: 471-474, 2006.
6. Fukui T, Rahman M, Shimbo T, Morita S, Sakamoto J. Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side. Intern Med 45: 511-514, 2006.
7. Goto K, Ito K, Sugiura T, Ando T, Mizutani F, Miyake Y, Kawabe Y, Sugiyama K, Togari H. Prevalence of hepatitis E virus infection in Japanese children. J Pediatr Gastroenterol Nutr. 42: 89-92, 2006.
8. Hibi K, Kusugami K, Ina K, Ando T, Komatsu Y, Kodera Y, Ito K, Akiyama S, T Nagasaka, Goto H, Nakao A. Disseminated intravascular coagulation associated with systemic cytomegalovirus infection during cyclosporine therapy for ulcerative colitis: report of a case. Dis Colon Rectum 49: 127-131, 2006.
9. Ishiyama A, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. PTCH gene expression as a potential marker for esophageal squamous cell carcinoma. Anticancer Res 26: 195-198, 2006.
10. Ito A, Ito K, Morishita M, Sakamoto T. A banana-allergic infant with IgE reactivity to avocado, but not to latex. Pediatr Int 48: 321-323, 2006.
11. Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F, Kato T, Tokita H, Izumi N, Kato M, M F. Yuen, C. L. Lai, R. G. Gish, Ueda R, Mizokami M. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 42: 1-7, 2006.
12. Ito K, Yamada Y, Naiki T, Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res 17: 579-586, 2006.
13. Kamei M, Morita S, Hayashi Y, Kanmura Y, Kuro M. Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: Rationale and design of the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT). Cardiovasc Drug Ther 20: 219-227, 2006.
14. Keohavong B, Syhakhang L, Sengaloundeth S, Nishimura A, Ito K. Rational use of drugs: prescribing and dispensing practices at public health facilities in Lao PDR. Pharmacoepidemiol Drug Saf 15: 344-347, 2006.
15. Kinouchi T, Sakamoto J, Tsukamoto T, Akaza H, Kubota Y, Ozono S, Kanetake H, Taguchi T, Kotake T. Immunotherapy oncology group for renal cell carcinoma: Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis. J Cancer Res Clin Oncol 132: 499-504, 2006.
16. Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Okabayashi T, Ichikawa K, Araki K. Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients. World J Gastroenterol 12: 1412-1415, 2006.
17. Kobayashi M, Tsuburaya A, Nagata N, Miyashita Y, Oba K, Sakamoto J. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer 9: 114-119, 2006.
18. Komatsu Y, Hibi K, Kodera Y, Akiyama S, Ito K, Nakao A. TAOS1, a novel marker for advanced esophageal squamous cell carcinoma. Anticancer Res 26: 2029-2032, 2006.
19. Matsui T, Omura K, Kawakami K, Morita S, Sakamoto J. Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer. Oncology Rep 16: 1111-1115, 2006.
20. Matsuyama Y, Morita S. Estimation of the average causal effect among subgroups defined by posttreatment variables. Clin Trials 3: 1-9, 2006.
21. Morioka Y, Hibi K, Sakai M, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer. Anticancer Res 26: 4267-4270, 2006.
22. Morioka Y, Hibi K, Sakai M, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Aberrant methylation of the CHFR gene in digestive tract cancer. Anticancer Res 26: 1791-1795, 2006.
23. Morita S, Fukuhara S, Akizawa T, Asano Y, Koshikawa S, Koide K, Kurokawa K. Prognostic Factors for a Composite Endpoint of Renal Outcomes in patients with Chronic Kidney Disease. Ther Apher Dial 10: 72-77, 2006.
24. Morita S, Kaptein A A, Tsuburaya A, Kodera Y, Matsui T, Sakamoto J. Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments. Gastric Cancer 9: 254-261, 2006.
25. Morita S, Kobayashi M, Oba K, Ichihara T, Nakao A, Sakamoto J. Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals and private general practitioners in Japan. Ann Cancer Res Ther 14: 1-11, 2006.
26. Morita S, Oka Y, Tsuboi A, Kawakami M, Maruno M, Izumoto S, Osaki T, Taguchi T, Ueda T, Myoui A, Nishida S, Shirakata T, Ohno S, Oji Y, Aozasa K, Hatazawa J, Udaka K, Yoshikawa H, Yoshimine T, Noguchi S, Kawase I, Nakatsuka S, Sugiyama H, Sakamoto J. A phase I/II trial of a WT1 (Wilm's Tumor Gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data. Jpn J Clin Oncol 36: 231-236, 2006.
27. Morita S, Sakamoto J. Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design. Pharmaceut Statist 5: 109-118, 2006.
28. Noguchi W, Morita S, Ohno T, Aihara O, Tsujii H, Shimozuma K, Matsushima E. Spiritual needs in cancer patients and spiritual care based on logotherapy. Support Care Cancer 14: 65-70, 2006.
29. Oba K, Morita S , Rahman M, Sakamoto J. Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial. Trials 7: 1-7, 2006.
30. Oba K, Morita S, Tsuburaya A, Kodera Y, Kobayashi M, Sakamoto J. Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally-randomized controlled clinical trials in Japan. J Chemother 18: 311-318, 2006.
31. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci 97:395-399, 2006.
32. Sakamoto J, Chin K, Kondo K, Kojima H, Terashima M, Yamamura Y, Tsujinaka T, Hyodo I, Koizumi W. Clinical Study Group of Capecitabine Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer. Anticancer Drugs 17: 231-236, 2006.
33. Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H, Ohashi Y. Efficacy of adjuvant immunchemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother 55: 404-411, 2006.
34. Sakamoto J, Oba K, Matsui T, Kobayashi M. Efficacy of oral anticancer agents for colorectal cancer. Dis Colon Rectum 49: 82-91, 2006.
35. Sakamoto J, Oba K, Matsui T, Kobayashi M. Evidence-based medicine in biotherapy for malignant tumor. Biotherapy 20: 363-373, 2006.
36. Sakamoto J, Oriuchi N, Mochiki E, Asao T, Scott AM, Hoffman EW, Jungbluth AA, Matsui T, Lee FT. A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. Cancer Sci 97: 1248-1254, 2006.
37. Sakamoto T, Tanaka Y, Orito E, Co J, Clavio J, Sugauchi F, Ito K, Ozasa A, Quino A, Ueda R, Sollano J, Mizokami M. Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J Gen Virol 87: 1873-1882, 2006.
38. Shinkai N, Tanaka Y, Orito E, Ito K, Ohno T, Hirashima N, Hasegawa I, Sugauchi F, Ueda, Mizokami M. Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection. Hepatol Res 36: 272-276,2006.
39. Shiraishi S, Kobayashi H, Nihashi T, Kato K, Iwano S, Nishino M, Ishigaki T, Ikeda M, Kato T, Ito K, Kimura T. Cerebral glucose metabolism change in patients with complex regional pain syndrome: a PET study. Radiat Med 24: 335-344, 2006.
40. Sugiura T, Goto K, Ito K, Ban K, Okada S, Moriyama A, Togari H. Effects of cyclosporine A in hyperzincaemia and hypercalprotectinaemia. Acta Paediatr 95: 857-860, 2006.
41. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, S. K. Acharya, R. G. Gish, A Kramvis, Shimada T, Izumi N, Kaito M, Miyakawa Y, Mizokami M. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44: 915-924, 2006.
42. Takahashi N, Kikuchi S, Konno S, Morita S, Suzukamo Y, Green J, Fukuhara S. Discrepancy between disability and the severity of low-back pain: demographic, psychological, and employment-related factors. Spine 31: 931-939, 2006.
43. Tanaka Y, Mukaide M, Orito E, M. F .Yuen, Ito K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, C. L. Lai, Ueda R, Mizokami M. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45: 646-653, 2006.
44. Tran TM, Nguyen HT, Yatsuya H, Hamajima N, Nishimura A, Ito K. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam. BMC Public Health 6: 248, 2006.
45. Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res 12: 3402-3407, 2006.
46. Wakabayashi N, Yamanaka J, Murai M, Ito K, Sawada T, Yonese M. Three-dimensional centimeter-sized colloidal silica crystals formed by addition of base. Langmuir 22: 7936-7941, 2006.

1. Akagi M, Mori S, Nishimura S, Nishimura A, Asano T, Hamanishi C. Variability of extraarticular tibial rotation references for total knee arthroplasty. Clin Orthop Relat Res 436: 172-176, 2005.
2. Fujiwara K., Tanaka Y, Orito E, Ohno T, Kato T, Sugihara K., Hasegawa I, Sakurai M, Ito K, Ozasa A., Sakamoto Y, Arita I, El-Gohary A, Benoit A, S. I. Ogoundele-Akplogan, Yoshihara N, Ueda R, Mizokami M. Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. World J Gastroenterol 11: 6410-6415, 2005.
3. Fujiwara K., Tanaka Y, Paulon E, Orito E, Sugiyama M, Ito K, Ueda R, Mizokami M, N. V. Naoumov. Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E. J Virol 79: 14404-14410, 2005.
4. Fujiwara M, Kodera Y, Miura S, Kanyama Y, Yokoyama H, Ohashi N, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a phase II study following the learning curve. J Surg Oncol 91: 26-32, 2005.
5. Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A. Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis. Dis Colon Rectum 48: 1282-1286, 2005.
6. Imamura Y, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer. Anticancer Res 48: 2627-2630, 2005.
7. Imazawa M, Hibi K, Fujitake S, Kodera Y, Ito K, Akiyama S, Nakao A. S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma. Anticancer Res 25: 1247-1250, 2005.
8. Inoue T, Hibi K, Nakayama G, Komatsu Y, Fukuoka T, Kodera Y, Ito K, Akiyama S, Nakao A. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer. J Gastroenterol 40: 143-147, 2005.
9. Kawai J, Kodera Y, Fujiwara M, Kasai Y, Nagasaka T, Koike M, Hibi K, Ito K, Akiyama S, Nakao A. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach. Hepatogastroenterology 52: 959-964,2005.
10. Kodera Y, Fujiwara M, Yokoyama H, Ohashi N, Miura S, Ito Y, Koike M, Ito K, Nakao A. Combination of oral fluoropyrimidine and docetaxel: reappraisal of synergistic effect against gastric carcinoma xenografts. In Vivo 19: 861-866, 2005.
11. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Fujiwara M, Koike M, Hibi K, Ito K, Tatematsu M, Nakao A. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer 8: 142-148, 2005.
12. Matsuyama Y, Yoshihara H, Tsuji T, Sakai Y, Yukawa Y, Nakamura H, Ito K, Ishiguro N. Surgical outcome of ossification of the posterior longitudinal ligament (OPLL) of the thoracic spine: implication of the type of ossification and surgical options. J Spinal Disord Tech 18: 492-497, 2005.
13. Ohya M, Yamada Y, Ozawa R, Ito K, Takahashi M, Ueda M. Sinus floor elevation applied tissue-engineered bone. Comparative study between mesenchymal stem cells/platelet-rich plasma (PRP) and autogenous bone with PRP complexes in rabbits. Clin Oral Implants Res 16: 622-629, 2005.
14. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K , Nakao A. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer 93: 799-803, 2005.
15. Sugiura T, Goto K, Ito K, Ueta A, Fujimoto S, Togari H. Chronic zinc toxicity in an infant who received zinc therapy for atopic dermatitis. Acta Paediatr 94: 1333-1335, 2005.

1. Akhmetov RT, Nishimura A. Kazakhstan health care reforms: compulsary medical insurance. J Central Asian Health Serv Res 3: 4-28, 2004.
2. Fujitake S, Hibi K., Okochi O, Kodera Y, Ito K., Akiyama S, Nakao A. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol 39: 120-124, 2004.
3. Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A. Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer 91: 1139-142, 2004.
4. Hibi K., Kodera Y, Ito K., Akiyama S, Shirane M, Nakao A. Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma. Anticancer Res 24: 3731-3734, 2004.
5. Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 90: 1030-1033, 2004.
6. Ito K., Hibi K., Kodera Y, Akiyama S, Nakao A. Prolonged cytostatic tumor dormancy induced by serial exchange of chemotherapy in colorectal carcinoma. Nagoya J Med Sci 67: 9-15, 2004.
7. Ito K., Nakazato H, Koike A., Takagi H, Saji S, Baba S, Mai M, Sakamoto J, Ohashi Y, P. S. K. f. C. C. Study Group of Immunochemotherapy. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int J Colorectal Dis 19: 157-164, 2004.
8. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M., Hibi K., Ito K., Akiyama S, Nakao A. Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology 51: 1225-1228, 2004.
9. Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Yamamura Y, Fujiwara M, Hibi K, Ito K., Akiyama S, Tatematsu M, Nakao A. Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Jpn J Clin Oncol 34: 525-531, 2004.
10. Mabuchi N, Watanabe H, Atsuta N, Hirayama M, Ito H, Fukatsu H, Kato T, Ito K, Sobue G. Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement. J Neurol Neurosurg Psychiatry 75: 1768-1771, 2004.
11. Miura S, Kodera Y, Fujiwara M, Ito S, Mochizuki Y, Yamamura Y, Hibi K., Ito K, Akiyama S, Nakao A. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg 198: 933-938, 2004.
12. Miyake M, Morishita M, Ito K, Ito A, Torii S, Sakamoto T. Production of granulomatous inflammation in lungs of rat pups and adults by Sephadex beads. Pediatr Res 56: 205-211, 2004.
13. Oda K, Akiyama S, Ito K, Kasai Y, Fujiwara M, Sekiguchi H, Nakao A, Sakamoto J. Perioperative prostaglandin E1 treatment for the prevention of postoperative complications after esophagectomy: a randomized clinical trial. Surg Today 34: 662-667, 2004.
14. Sakakibara T, Hibi K., Kodera Y, Ito K., Akiyama S, Nakao A. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of esophageal squamous cell carcinoma. Clin Cancer Res 10: 1375-1378, 2004.
15. Sairenchi T, Iso H, Nishimura A, Hosoda T, Irie F, Saito Y, Murakami A, Fukutomi H. Cigarette smoking and risk of type 2 diabetes mellitus among middle-aged and elderly Japanese men and women. Am J Epidemiol 160: 158-162, 2004.
16. Tanaka Y, A.E. Yeo, Orito E, Ito K., Hirashima N, Ide T, Sata M, Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection. J Gastroenterol 39: 769-775, 2004.

1. Fujiwara M, Kodera Y, Kasai Y, Kanyama Y, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg 196: 75-81, 2003.
2. Hibi K, Fujitake S, Takase T, Kodera Y, Ito K, Akiyama S, Shirane M, Nakao A. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway. Clin Cancer Res 9: 4282-4285, 2003.
3. Hibi K, Koike M, Nakayama H, Fujitake S, Kasai Y, Ito K, Akiyama S, Nakao A. A cancer-prone case with a background of methylation of p16 tumor suppressor gene. Clin Cancer Res 9: 1053-1056, 2003.
4. Hibi K, Nakayama H, Kanyama Y, Kodera Y, Ito K, Akiyama S, Nakao A. Methylation pattern of HLTF gene in digestive tract cancers. Int J Cancer 104: 433-436, 2003.
5. Hidemura K, Zhao YL, Ito K, Nakao A, Tatsumi Y, Kanazawa H, Takagi K, Ohta M, Hasegawa T. Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2. Antimicrob Agents Chemother 47: 1636-1642, 2003.
6. Kanyama Y, Fujiwara M, Kodera Y, Miura S, Kasai Y, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopic distal gastrectomy for severe corrosive gastritis: report of a case. Surg Today 33: 937-939, 2003.
7. Kanyama Y, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A. Detection of p16 promoter hypermethylation in serum of gastric cancer patients. Cancer Sci 94: 418-420, 2003.
8. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, Ito K, Akiyama S, Nakao A. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 10: 898-902,2003.
9. Mochizuki Y, Akiyama S, Koike M, Kodera Y, Ito K, Nakao A. A peptic ulcer in a reconstructed gastric tube perforating the thoracic aorta after esophageal replacement. Jpn J Thorac Cardiovasc Surg 51: 448-451, 2003.
10. Nakanishi H, Mochizuki Y, Kodera Y, Ito S, Yamamura Y, Ito K, Akiyama S, Nakao A, Tatematsu M. Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Cancer Sci 94: 112-118, 2003.
11. Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S, Nakao A. Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int J Cancer 105: 491-493, 2003.
12. Takase T, Hibi K, Yamazaki T, Nakayama H, Taguchi M, Kasai Y, Ito K, Akiyama S, Nagasaka T, Nakao A.. PGP9.5 overexpression in esophageal squamous cell carcinoma. Hepatogastroenterology 50: 1278-1280, 2003.

Generation 19(2021-22) △
1. Tun KK, Inthaphatha S, Soe MM, Nishino K, Hamajima N, Yamamoto E. Causes of death, three delays, and factors associated with Delay 1 among maternal deaths in Myanmar: The maternal death surveillance in 2019. Midwifery 121:103657. doi: 10.1016/j.midw, 2023.

Generation 18(2020-21) △
2. Khalid KH, Yamamoto E, Hamajima N, Kariya T. Rates and Factors Associated With Serious Outcomes of Patient Safety Incidents in Malaysia: An Observational Study. Global J Quality and Safety in Healthcare 5: 31-38, 2022.
3. Moeun, S, Bhoomikumar J, Pat P, Kariya T, Suzuki Y, Hamajima N, Sok D, Yamamoto E. Children with neuro-developmental disorders at Center for Child and Adolescent Mental Health in Cambodia. Nagoya J Med Sci 84: 593-606, 2022.
4. Sonsupap C, Pokhakul P, Kariya T, Suzuki Y, Hamajima N, Yamamoto E. Characteristics of adverse drug reactions due to nonsteroidal anti-inflammatory drugs: a cross-sectional study. Nagoya J Med Sci, in press
5. Sirait LMF, Hamajima N, Suzuki Y, Wahyuningsih ES, Oktavia D, Widyastuti, Inthaphatha S, Nishino K, Yamamoto E. Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: A cross-sectional study. BMC Cancer 22: 1309, 2022.

Generation 17(2019-20) △
6. Thinakaran MS, Yamamoto E, Saw YM, Kariya T, Hamajima N. Satisfaction With Health Care Services at the Pediatric Specialist Clinic of the National Referral Center in Malaysia: Cross-sectional Study of Caregivers' Perspectives. JMIRx Med 3:e33025, 2022.
7. Batbayar B, Kariya T, Boldoo T, Purevdorj E, Dambaa N, Saw YM, Yamamoto E, Hamajima N. Patient delay and health system delay of patients with newly diagnosed pulmonary tuberculosis in Mongolia, 2016-2017. Nagoya J Med Sci 84:339-351, 2022.
8. Senavong P, Yamamoto E, Keomoungkhoune P, Prasith N, Somoulay V, Kariya T, Saw YM, Pongvongsa T, Hamajima N. Factors associated with severe dengue in Savannakhet Province, Lao People's Democratic Republic. Nagoya J Med Sci 83:749-763, 2021.
9. Noe MTN, Saw YM, Saw TN, Kyaw YP, Zin PE, Cho SM, Kariya T, Yamamoto E, Win HH, Wann T, Hamajima N. Assessment of nutritional status and risk factors for malnutrition among the elderly in Loikaw, Myanma. Nutrition 79-80:110933, 2020.
10. Zin PE, Saw YM, Saw TN, Cho SM, Hlaing SS, Noe MTN, Kariya T, Yamamoto E, Lwin KT, Win HH, Hamajima N. Assessment of quality of life among elderly in urban and peri-urban areas, Yangon Region, Myanmar. PLoS One 15(10):e0241211, 2020.

Generation 16(2018-19) △
11. Keng ZY, Saw YM, Thung SC, Chong WW, Albert A, Kariya T, Yamamoto E, Hamajima N. Rate of achievement of therapeutic outcomes and factors associated with control of non-communicable diseases in rural east Malaysia: implications for policy and practice. Sci Rep11: 3812, 2021
12. Htet H, Saw YM, Saw TN, Htun NMM, Lay Mon K, Cho SM, Thike T, Khine AT, Kariya T, Yamamoto E, Hamajima N. Prevalence of alcohol consumption and its risk factors among university students: A cross-sectional study across six universities in Myanmar. PLoS One 15(2):e0229329, 2020.
13. Khine AT, Saw YM, Htut ZY, Khaing CT, Soe HZ, Swe KK, Thike T, Htet H, Saw TN, Cho SM, Kariya T, Yamamoto E, Hamajima N. Assessing risk factors and impact of cyberbullying victimization among university students in Myanmar: A cross-sectional study. PLoS One 15(1):e0227051, 2020.
14. Thike TZ, Saw YM, Lin H, Chit K, Tun AB, Htet H, Cho SM, Khine AT, Saw TN, Kariya T, Yamamoto E, Hamajima N. Association between body mass index and ready-to-eat food consumption among sedentary staff in Nay Pyi Taw union territory, Myanmar. BMC Public Health 20(1):206, 2020.
15. Wasiq AN, Saw YM, Jawid S, Kariya T, Yamamoto E, Hamajima N. Determinants of diarrhea in children under the age of five in Afghanistan: a secondary analysis of the Afghanistan Demographic and Health Survey 2015. Nagoya J Med Sci 82(3):545-556, 2020.
16. Leak P, Yamamoto E, Noy P, Keo D, Krang S, Kariya T, Saw YM, Meng S, Hamajima N. Factors associated with neonatal mortality in a tertiary hospital in Phnom Penh, Cambodia. Nagoya J Med Sci (in press)

Generation 15(2017-18) △
17. Aung ZZ, Saw YM, Saw TN, Oo N, Aye HNN, Aung S, Oo HN, Cho SM, Khaing M, Kariya T, Yamamoto E, Hamajima N. Survival rate and mortality risk factors among TB-HIV co-infected patients at a HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study. Int J Infect Dis 80: 10-15, 2019.
18. Aye HNN, Saw YM, Thar AMC, Oo N, Aung ZZ, Tin H, Tetsuyoshi K, Yamamoto E, Hamajima N. Accessing the operational costs of routine immunization activities at sub-centers level by geographic areas in Myanmar: what matters to increase a national immunization coverage? Vaccine 36: 7542-7548, 2018.
19. Azimi MW, Yamamoto E, Saw YM Kariya T, Arab AS, Sadaat SI, Farzad F, Hamajima N. Factors associated with antenatal care visits in Afghanistan: secondary analysis of Afghanistan Demographic and Health Survey 2015. Nagoya J Med Sci 81: 121-131, 2019.
20. Kaur J, Hamajima N, Yamamoto E, Saw YM, Kariya T, Soon GC, Amin A, Halim AN, Aziz FA, Sharon SH. Patient Satisfaction on the utilization of traditional and complementary medicine services at public hospitals in Malaysia. Complement Ther Med 42: 422-428, 2019.
21. Long-Hay P, Yamamoto E, Bun S, Savuth T, Buntha S, Sokdaro S, Kariya T, Saw YM, Sengdoeurn Y, Hamajima N. Outbreak detection of influenza-like illness in Prey Veng Province, Cambodia: A community-based surveillance. Nagoya J Med Sci 81: 269-280, 2019.
22. Oo N, Saw YM, Aye HNN, Aung ZZ, Kyaw HN, Tun AM, Kariya T, Yamamoto E, Hamajima N. Consumption of foods containing prohibited artificial colors among middle-school children in Nay Pyi Taw Union Territory, Myanmar. BMC Public Health 19: 344, 2019.
23. Taazan B, Yamamoto E, Baatar B, Amgalanbaatar A, Kariya T, Saw YM, Hamajima N. Estimating cost of hospitalization for childbirth at a tertiary hospital in Mongolia. Nagoya J Med Sci 82(1):47-57, 2020.

Generation 14(2016-17) △
24. Nguyen STT, Yamamoto E, Nguyen MTN, Le HB, Kariya T, Saw YM, Nguyen CD, Hamajima N. Waiting time in the outpatients clinic at a national hospital in Vietnam. Nagoya J Med Sci 80: 227-239, 2018.
25. Orsoo O, Saw YM, Sereenen E, Yadamsuren B, Byambaa A, Kariya T, Yamamoto E, Hamajima N. Epidemiological characteristics and trends of a nationwide measles outbreak in Mongolia, 2015-2016. BMC Public Health 19: 201, 2019.
26. Rasekh B, Saw YM, Azimi S, Kariya T, Yamamoto E, Hamajima N. Associations of treatment completion against drug addiction with motivational interviewing and related factors in Afghanistan. Nagoya J Med Sci 80: 329-340, 2018.
27. Than TM, Saw YM, Khaing M, Win EM, Cho SM, Kariya T, Yamamoto E, Hamajima N. Unit cost of healthcare services at 200-bed public hospitals in Myanmar: what plays an important role of hospital budgeting? BMC Health Serv Res 17: 669, 2017.
28. Win EM, Saw YM, Oo KL, Than TM, Cho SM, Kariya T, Yamamoto E, Hamajima N. Healthcare waste management at primary health centres in Mon State, Myanmar: the comparisons between hospital and non-hospital type primary health centres. Nagoya J Med Sci 81: 81-91, 2019.
29. Houattongkham S, Yamamoto E, Sithivong N, Inthaphatha S, Kariya T, Saw YM, Vongduangchanh A, Keosavanh O, Hamajima N. Etiologic agents of acute diarrhea in sentinel surveillance sites in Vientiane Capital, Lao People's Democratic Republic, 2012-2015. Eur J Clin Microbiol Infect Dis 39(6):1115-1122, 2020.

Generation 13(2015-16) △
30. Chankham T, Yamamoto E, Reyer JA, Arafat R, Khonemany I, Panome S, Hongkham D, Bounfeng P, Anonh X, Hamajima N. Knowledge of free delivery policy among women who delivered at health facilities in Oudomxay Province, Lao PDR. Nagoya J Med Sci 79: 135-145, 2017.
31. Farzad F, Reyer JA, Yamamoto E, Hamajima N. Socio-economic and demographic determinants of full immunization among children of 12-23 months in Afghanistan. Nagoya J Med Sci 79: 179-188, 2017.
32. Inthanomchanh V, Reyer JA, Blessmen J, Phrasisombath K, Yamamoto E, Hamajima N. Assessment of knowledge about snakebite management amongst health care providers in the provincial and two district hospitals in Savannakhet Province, Lao PDR. Nagoya J Med Sci 79: 299-311, 2017.
33. Htin Aung Myint MN, Yamamoto E, Ko MN, Khaing M, Reyer JA, Hamajima N. Knowledge, attitude, and usage pattern of tobacco among high school students in Nay Pyi Taw, Mynamar. Nagoya J Med Sci 81: 65-79, 2019.
34. Tursunov D, Yoshida Y, Yrysov K, Sabirov D, Alimova K, Yamamoto E, Reyer JA, Hamajima N. Estimated costs for treatment and prophylaxis of newborn vitamin K deficiency bleeding in Tashkent, Uzbekistan. Nagoya J Med Sci 80: 11-20, 2018.
35. Yrysov K, Tursunov D, Reyer JA, Yamamoto E, Yrysova M, Hamajima N. Multiple ruptured cerebral aneurysms at the National Hospital of the Kyrgyz Republic between 2008 and 2014: A departmental summary. Nagoya J Med Sci 81: 511-518, 2019.

Generation 12(2014-15) △
36. Frozanfar MK, Yoshida Y, Yamamoto E, Reyer JA., Dalil S, Rahimzad AD, Hamajima N. Acute malnutrition among under-five children in Faryab, Afghanistan: prevalence and causes. Nagoya J Med Sci 78: 41-53, 2016.
37. Ganieva U, Alimdjanov I, Ganieva M, Abdunazarov T. Drug use in children hospitalized with cardio-rheumatologic diseases in Andijan, Uzbekistan: a cross-sectional descriptive study. BMC Pharmacol Toxicol 17: 11, 2016.
38. Htun MMN, Reyer JA, Yamamoto E, Yoshida Y, Hamajima N. Trends in attrition among medical teaching staff at universities in Myanmar 2009-2013. Nagoya J Med Sci 78: 27-40, 2016.
39. Pillai CPK, Yoshida Y, Lawrence PJ, Yamamoto E, Reyer JA, Hamajima N. Pediatric cardiothoracic program in Malaysia: a study based on the outcome of the program. Nagoya J Med Sci 78: 9-17, 2016.
40. Sansam S, Yamamoto E, Srun S, Sinath Y, Moniborin M, Sim KB, Reyer JA, Yoshida Y, Hamajima N. Assessment of hand hygiene compliance after hand hygiene education among health workers in Cambodia. Nagoya J Med Sci 78: 151-162, 2016.
41. Sharam SM, Hamajima N, Reyer JA. Factors affecting maternal healthcare utilization in Afghanistan: secondary analysis of Afghanistan Health Survey 2012. Nagoya J Med Sci 77: 595-607, 2015.
42. Shayahmetov B, Yoshida Y, Yamamoto E, Reyer JA, Hamajima N. The Study on Patient Dissatisfaction with Medical Services to define an Indicator of the Healthcare Management in the Ton and Issyk-Kul Regional Hospitals of Kyrgyzstan. Health Edu Care 1: 41-44, 2016.
43. Surenjav E, Sovd T, Yoshida Y, Yamamoto E, Reyer JA, Hamajima N. Trends in amenable mortality rate in the Mongolian population, 2007-2014. Nagoya J Med Sci 78: 55-68, 2016.

Generation 11(2013-14) △
44. Toe SY, Higuchi M, Htay SS, Hamajima N. Health care seeking behaviors regarding maternal care and the associated factors among married women in Naung Cho Township, Myanmar. Nagoya J Med Sci 83: 727-740, 2021
45. Ahadi SSM, Yoshida Y, Sarker MA, Reyer JA, Hamajima N. Clinical features, current treatments and outcome of pregnant women with preeclampsia/eclampsia in northern Afghanistan. Nagoya J Med Sci 77: 103-111, 2015.
46. Alam Z, Higuchi M, Sarker MAB, Hamajima N. Mass media exposure and childhood diarrhea: A secondary analysis of the 2011 Bangladesh Demographic and Health Survey. Nagoya J Med Sci 81: 31-40, 2019.
47. Asaduzzaman M, Higuchi M, Sarker MA, Hamajima N. Awareness and knowledge of HIV/AIDS among married women in rural Bangladesh and exposure to media: a secondary data analysis of the 2011 Bangladesh Demographic and Health Sruvey. Nagoya J Med Sci 78: 109-118, 2016.
48. Chanvilay T, Yoshida Y, Reyer J, Hamajima N, Bounpheng P. Factors associated with access to antiretroviral therapy among people living with HIV in Vientian capital, Lao PDR. Nagoya J Med Sci 77: 29-39, 2015.
49. Khammany P, Yoshida Y, Sarker MA, Touy C, Reyer JA, Hamajima N. Delivery care satisfaction at government hospitals in Xiengkhuang providence under the maternal and child health startegy in Lao PDR. Nagoya J Med Sci 77: 69-79, 2015.
50. Osmani AK, Reyer JA, Osmani AR, Hamajima N. Factor influencing contraceptive use among women in Afghanistan: secondary analysis of the Afghanistan Health Survey 2012. Nagoya J Med Sci 77: 551-561, 2015.
51. Sor S, Higuchi M, Sarker MAB, Hamajima N. Knowledge of rabies and dog-related behaviors among people in Siem Reap Province, Cambodia. Trop Med Health 46: 20, 2018.
52. Suvanbekov A, Kitarova G, Reyer J A, Hamajima N. Progress toward measles elimination in Kyrgyzstan. Nagoya J Med Sci 77: 179-188, 2015.

Generation 10(2012-13) △
53. Aigul B, Higuchi M, Sarker MA, Alim MA, Hamajima N. Tuberculosis and rifampicin resistance among migrants in Kyrgyztan: Detection by a new diagnostic test. Nagoya J Med Sci 77: 41-49, 2015.
54. Alim MA, Sarker MA, Selim S, Karim MR, Yoshida Y, Hamajima N. Respiratory involvements among women exposed to the smoke of traditional biomass fuel and gas fuel in a district of Bangladesh. Envrion Health Prev Med 19: 126-134, 2014.
55. Amonov M, Yoshida Y, Toirov E, Davlatov S, Hamajima N. Hypertension related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. Nagoya J Med Sci 76: 255-263, 2014.
56. Azimi MD, Najafizada SAM, Khaing IK, Hamajima N. Factors influencing non-institutional deliveries in Afghanistan: secondary analysis of the Afghanistan Mortality Survey 2010. Nagoya J Med Sci 77: 133-143, 2015.
57. Fayaz SH, Higuchi M, Hirosawa T, Sarker MA, Djabbarova Z, Hamajima N. Knowledge and practice of universal precautions among health care workers in four national hospitals in Kabul, Afghanistan. J Infect Dev Countr 8: 535-542, 2014.
58. Khaing IK, Amonov M, Oo M, Hamajima N. Health care expenditure of households in Magway, Myanmar. Nagoya J Med Sci 77: 203-212, 2015.
59. Narin P, Hamajima N, Kouy S, Hirosawa T, Eav S. Characteristics of liver cancer at Khmer-Soviet Friendship hospital in Phnom Penh, Cambodia. Asian Pac J Cancer Prev 16: 35-39, 2015.
60. Yingtaweesak T, Yoshida Y, Hemhongsa P, Hamajima N, Chaiyakae S. Accessibility of health care service in Thasongyang, Tak Province, Thailand. Nagoya J Med Sci 75: 243-250, 2013.

Generation 9(2011-12) △
61. Hamrah S, Harun-Or-Rashid M, Hirosawa T, Sakamoto J, Hashemi H, Emamian H, Shariati M, Fotouhi A. Smoking and its associated factors among population aged 40-64 in Shahroud, Iran. Asian Pac J Cancer Prev 14: 1919-1923, 2013.
62. Piotrowski J, Harun-Or-Rashid M, Hirosawa T, Sakamoto J, Evaluation of the national breast cancer screening program in Poland in 1999-2009. National Cancer Registry overview. Ann Cancer Res Ther 20: 39-46, 2012.
63. Senbounsou K, Harun-Or-Rashid M, Sarker MA, Hirosawa T, Outavong P, Sakamoto J. Job satisfaction of Health-Care Workers at Health Centers in Vientiane Capital and Bolikhamsai Province, Lao PDR., Nagoya J Med Sci 75: 233-241, 2013.
64. Lo N, Sarker M, Lim Y, Rashid H, Sakamoto J. Inadequate water treatment quality as assessed by protozoa removal in Sarawak, Malaysia. Nagoya J Med Sci 80: 165-174, 2018.
65. Srisawang P, Harun-Or-Rashid M, Hirosawa T, Sakamoto J. Knowledge, Attitudes and barriers of physicains, policy makers/regulators regarding use of opiods for cancer pain management in Thailand. Nagoya J Med Sci 75: 201-212, 2013.

Generation 8(2010-11) △
66. Jumayev I, Harun-Or-Rashid M, Rustamov O, Zakirova N, Kasuya H, Sakamoto J. Social correlates of female infertility in Uzabekistan. Nagoya J Med Sci 74: 273-283, 2012.
67. Khandarmaa TO, Harun-Or-Rashid M, Sakamoto J. Risk factors of burns among children in Mongolia. Burns 38: 751-757, 2012.
68. Musa MB, Harun-Or-Rashid M, Sakamoto J. Nurse managers' experience with ethical issues in six government hospitals in Malaysia: A cross-sectional study. BMC Med Ethics 12: 23, 2011.
69. Samrith W, Rahman M, Harun-Or-Rashid M, Sakamoto J. Trends and barriers to HIV testing among tuberculosis patients in Prey Kabbas operational district, Takeo province, Cambodia. Asia Pac J Public Health 27: NP789-797, 2015.
70. Sarker MA, Rahman M, Harun-Or-Rashid M, Hossain S, Kasuya H, Sakamoto J, Hamajima N. Association of smoked and smokeless tobacco use with migraine: a hospital-based case-control study in Dhaka, Bangladesh. Tob Induc Dis 11: 15, 2013.
71. Thanavanh B, Harun-Or-Rashid M, Kasuya H, Sakamoto J. Knowledge, attitudes and practices regarding HIV/AIDS among male high school students in Lao People's Democratic Republic. J Int AIDS Soc 16: 17387, 2013.
72. Thu TA, Hung NV, Quang NN, Archibald LK, Thuy le TT, Harun-Or-Rashid M, Sakamoto J. A point-prevalence study on healthcare-associated infections in Vietnam: public health implications. Infect Control Hosp Epidemiol 32: 1039-1041, 2011.
73. Widsanugorn O, Suwattana O, Harun-Or-Rashid M, Sakamoto J. Healthcare workers' knowledge and practices regarding expanded program on immunization in Kalasin, Thailand. Nagoya J Med Sci 73: 177-185, 2011.

Generation 7(2009-10) △
74. Dao HH, Harun-Or-Rashid M, Sakamoto J. Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford )49: 2400-2407, 2010.
75. Kambaralieva B, Bozgunchiev M, Zurdinov A, Harun-Or-Rashid M, Sakamoto J. An assessment of antibiotics prescribed at the secondary health-care level in the Kyrgyz Republic. Nagoya J Med Sci 73: 157-168, 2011.
76. Khun M, Heng C, Harun-Or-Rashid M, Kasuya H, Sakamoto J. Knowledge, attitudes, and practices (KAPs) towards avian influenza A (H5N1) among Cambodian women: a cross-sectional study. Asian Pac J Trop Med 5: 727-734, 2012.
77. Le H, Harun-Or-Rashid M, Yoshida Y, Sakamoto J. Adverse drug reactions to antibiotics from spontaneous reporting system of Vietnam in 2007. Vietnam J Med Pharm. 3:51-61, 2013.
78. Ongoagchai S, Harun-Or-Rashid M, Sakamoto J. Factors affecting drug quality problems in Thailand. Qual Assur J 14: 9-17, 2011.

Generation 6(2008-09) △
79. Aimukhametova G, Ukybasova T, Hamidullina Z, Zhubanysheva K, Harun-Or-Rashid M, Yoshida Y, Kasuya H, Sakamoto J. The impact of maternal obesity on mother and neonatal health: study in a tertiary hospital of Astana, Kazakhstan. Nagoya J Med Sci 74: 83-92, 2012.
80. Htay SS, Oo M, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Risk behaviours and associated factors among medical students and community youths in Myanmar. Nagoya J Med Sci 72: 71-81, 2010.
81. Kulkayeva G, Harun-Or-Rashid M, Yoshida Y, Tulebayev K, Sakamoto J. Cardiovascular disease risk factors among rural Kazakh population. Nagoya J Med Sci 74: 51-61, 2012.
82. Mamarajabov S, Kodera Y, Karimov S, Abdiev S, Sabirov B, Krotov N, Kurbaniyazov Z, Arziev I, Sattarov S, Fayziev T, Yoshida Y, Nakao A, Sakamoto J. Surgical alternatives for hepatic hydatid disease. Hepatogastroenterology 58: 1859-1861, 2011.
83. Pulatova G, Harun-Or-Rashid M, Yoshida Y, Sakamoto J. Elderly health and its correlations among Uzbek population. Nagoya J Med Sci 74: 71-82, 2012.
84. Rakchanok N, Amporn D, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Dental caries and gingivitis among pregnant and non-pregnant women in Chiang Mai, Thailand. Nagoya J Med Sci 72: 43-50, 2010.
85. Viengsakhone L, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Factors affecting low birth weight at four central hospitals in Vientiane, Lao PDR. Nagoya J Med Sci 72: 51-58, 2010.
86. Ye Y, Yoshida Y, Harun-Or-Rashid M, Sakamoto J. Factors affecting the utilization of antenatal care services among women in Kham District, Xiengkhouang province, Lao PDR. Nagoya J Med Sci 72: 23-33, 2010.

Generation 5(2007-08) △
87. Bayarmaa C, Ganbold L, Sakamoto J, Hamajima N. Disaster and emergency preparedness of hospitals in Mongolia. Southeast Asian J Trop Med Public Health 40: 16-22. 2009.
88. Guo L, Jiang Y, Yatsuya H, Yoshida Y, Sakamoto J. Group education with personal rehabilitation for idiopathic Parkinson's disease. Can J Neurol Sci 36: 51-59, 2009.

Generation 4(2006-07) △
89. Abdiev S, Ahn KS, Rahimov B, Bahramov S, Malikov YR, Khadjibaev AM, Kurbanov F, Hamajima N. Helicobacter pylori infection and peptic ulcer disease in Uzbekistan. Helicobacter 13: 304-305, 2008.
90. Enkhbold S, Tugsdelger S, Morita S, Sakamoto J, Hamajima N. HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. Nagoya J Med Sci 69: 157-165, 2007.
91. Harun-Or-Rashid M, Khatun UF, Yoshida Y, Morita S, Chowdhury N, Sakamoto J. Iron and iodine deficiencies among under-2 children, adolescent girls, and pregnant women of Bangladesh: association with common diseases. Nagoya J Med Sci 71: 39-49, 2009.
92. Heng LS, Yatsuya H, Morita S, Sakamoto J. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis. J Epidemiol 20: 70-76, 2010.
93. Nalongsack S, Yoshida Y, Morita S, Sosouphanh K, Sakamoto J. Knowledge, attitude and practice regarding dengue among people in Pakse, Laos. Nagoya J Med Sci 71: 29-37, 2009.
94. Nguyen TL, Nguyen TH, Morita S, Sakamoto J. Injury and pre-hospital trauma care in Hanoi, Vietnam. Injury 39: 1026-1033, 2008.

Generation 3(2005-06) △
95. Baigalmaa D, Nishimura A, Ito K. Smoking cessation rate 12 months after a group counseling program in Mongolia. Asian Pac J Cancer Prev 7: 399-402, 2006.
96. Bozgunchievz M, Ito K. Avoidable mortality measured by years of potential life lost (YPLL) aged 5 before 65 years in Kyrgyzstan, 1989-2003. Nagoya J Med Sci 69: 61-70, 2007.
97. Khalequzzaman M, Kamijima M, Sakai K, Chowdhury NA, Hamajima N, Nakajima T. Indoor air pollution and its impact on children under five years old in Bangladesh. Indoor Air 17: 297-304, 2007.
98. Khieu K, Ito K, Hamajima N. Experience in tuberculosis treatment through directly observed therapy short course in health centres and communities in Cambodia. Public Health 121: 696-699, 2007.
99. Shimarova M, Nishimura A, Ito K, Hamajima N. Effectiveness of implementation of gastric and duodenal ulcer clinical protocol in the Kyrgyz Republic. Nagoya J Med Sci 69: 55-59, 2007.
100. Shinee E, Gombojav E, Nishimura A, Hamajima N, Ito K. Healthcare waste management in the capital city of Mongolia. Waste Manag 28: 435-441, 2008.
101. Palanuwong B. Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand. Aust N Z J Obstet Gynaecol 47: 54-60, 2007.
102. Petju M, Suteerayongprasert A, Thongpud R, Hassiri K. Importance of dental records for victim identification following the Indian Ocean tsunami disaster in Thailand. Public Health 121: 251-257, 2007.
103. Uy S, Akashi H, Taki K, Ito K. Current problems in national hospitals of Phnom Penh: finance and health care. Nagoya J Med Sci 69: 71-79, 2007.

Generation 2(2004-05) △
104. Baizhumanova A, Nishimura A, Ito K, Sakamoto J, Karsybekova N, Tsoi I, Hamajima N. Effectiveness of communication campaign on iron deficiency anemia in Kyzyl-Orda region, Kazakhstan: a pilot study. BMC Blood Disord 10: 2, 2010.
105. Chen XY, Yamauchi K, Kato K, Nishimura A, Ito K. Using the balanced scorecard to measure Chinese and Japanese hospital performance. Int J Health Care Qual Assur Inc Leadersh Health Serv19: 339-350, 2006.(JDS)
106. Keohavong B, Syhakhang L, Sengaloundeth S, Nishimura A, Ito K. Rational use of drugs : prescribing and dispensing practices at public health facilities in Lao PDR. Pharmacoepidemiol Drug Saf 15: 344-347, 2006.
107. Tran TM, Nguyen HT, Yatsuya H, Hamajima N, Nishimura A, Ito K. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam. BMC Public Health 6: 248, 2006.

Generation 1(2003-04)) △
108. Akhmetov RT, Nishimura A. Kazakhstan health care reforms: compulsory medical Insurance. J Central Asian Health Serv Res 3: 4-28, 2004.